Teradyne, Inc 10-Q for FY2020 Q1
Teradyne, Inc (TER)
10-Q
2020-05-04
For: 2020-03-29
View Original
Added on
April 10, 2026
About this 10-Q
Teradyne, Inc filed this 10-Q on May 4, 2020, covering the quarter ended March 29, 2020 (FY2020 Q1).
Headline figures
Quarter ended March 29, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $704.36M
- up 42.6% from $494.1M a year earlier
- Net income
- $176.19M
- up 61.4% from net income of $109.14M a year earlier
- Diluted EPS
- $0.97
- up 56.5% from $0.62 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 29, 2020
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File No. 001-06462
(Exact name of registrant as specified in its charter)
(State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) | |
(Address of Principal Executive Offices) |
(Zip Code) |
(Registrant’s Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Indicate by
check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days.
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation Yes
S-T
(232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files) ☒
No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2
of the Exchange Act (check one): ☒ |
Accelerated filer |
☐ | ||||
Non-accelerated filer |
☐ |
Emerging growth company |
||||
Smaller reporting company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule ☒
12b-2
of the Exchange Act). Yes ☐
No The number of shares outstanding of the registrant’s only class of Common Stock as of April 2, 2020 was 165,768,292 shares.
7
TERADYNE, INC.
INDEX
Page No. |
||||||
Item 1. |
||||||
1 |
||||||
2 |
||||||
3 |
||||||
4 |
||||||
5 |
||||||
6 |
||||||
Item 2. |
27 |
|||||
Item 3. |
36 |
|||||
Item 4. |
37 |
|||||
Item 1. |
38 |
|||||
Item 1A. |
38 |
|||||
Item 2. |
39 |
|||||
Item 4. |
40 |
|||||
Item 6. |
41 |
|||||
PART I
Item 1: |
Financial Statements |
TERADYNE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
| March 29, 2020 |
December 31, 2019 |
|||||||
| (in thousands, except per share information) |
||||||||
| ASSETS |
||||||||
| Current assets: |
||||||||
| Cash and cash equivalents |
$ | |
$ | |
||||
| Marketable securities |
|
|
||||||
| Accounts receivable, less allowance for doubtful accounts of $ |
|
|
||||||
| Inventories, net |
|
|
||||||
| Prepayments and other current assets |
|
|
||||||
| Total current assets |
|
|
||||||
| Property, plant and equipment, net |
|
|
||||||
| Operating lease right-of-use assets, net |
|
|
||||||
| Marketable securities |
|
|
||||||
| Deferred tax assets |
|
|
||||||
| Retirement plans assets |
|
|
||||||
| Other assets |
|
|
||||||
| Acquired intangible assets, net |
|
|
||||||
| Goodwill |
|
|
||||||
| Total assets |
$ | |
$ | |
||||
| LIABILITIES |
||||||||
| Current liabilities: |
||||||||
| Accounts payable |
$ | |
$ | |
||||
| Accrued employees’ compensation and withholdings |
|
|
||||||
| Deferred revenue and customer advances |
|
|
||||||
| Other accrued liabilities |
|
|
||||||
| Operating lease liabilities |
|
|
||||||
| Contingent consideration |
|
|
||||||
| Income taxes payable |
|
|
||||||
| Total current liabilities |
|
|
||||||
| Retirement plans liabilities |
|
|
||||||
| Long-term deferred revenue and customer advances |
|
|
||||||
| Long-term other accrued liabilities |
|
|
||||||
| Long-term contingent consideration |
|
|
||||||
| Deferred tax liabilities |
|
|
||||||
| Long-term operating lease liabilities |
|
|
||||||
| Long-term incomes taxes payable |
|
|
||||||
| Debt |
|
|
||||||
| Total liabilities |
|
|
||||||
| Commitments and contingencies (See Note Q ) |
||||||||
| SHAREHOLDERS’ EQUITY |
||||||||
| Common stock, $ , |
|
|
||||||
| Additional paid-in capital |
|
|
||||||
| Accumulated other comprehensive loss |
( |
) | ( |
) | ||||
| Accumulated deficit |
( |
) | ( |
) | ||||
| Total shareholders’ equity |
|
|
||||||
| Total liabilities and shareholders’ equity |
$ | |
$ | |
||||
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2019, are an integral part of the condensedconsolidated financial statements.
1
TERADYNE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
| For the Three Months Ended |
||||||||
| March 29, 2020 |
March 31, 2019 |
|||||||
| (in thousands, except per share amounts) |
||||||||
| Revenues: |
||||||||
| Products |
$ | |
$ | |
||||
| Services |
|
|
||||||
| Total revenues |
|
|
||||||
| Cost of revenues: |
||||||||
| Cost of products |
|
|
||||||
| Cost of services |
|
|
||||||
| Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below) |
|
|
||||||
| Gross profit |
|
|
||||||
| Operating expenses: |
||||||||
| Selling and administrative |
|
|
||||||
| Engineering and development |
|
|
||||||
| Acquired intangible assets amortization |
|
|
||||||
| Restructuring and other |
( |
) | |
|||||
| Total operating expenses |
|
|
||||||
| Income from operations |
|
|
||||||
| Non-operating (income) expense: |
||||||||
| Interest income |
( |
) | ( |
) | ||||
| Interest expense |
|
|
||||||
| Other (income) expense, net |
|
( |
) | |||||
| Income before income taxes |
|
|
||||||
| Income tax provision (benefit) |
|
( |
) | |||||
| Net income |
$ | |
$ | |
||||
| Net income per common share: |
||||||||
| Basic |
$ | |
$ | |
||||
| Diluted |
$ | |
$ | |
||||
| Weighted average common shares—basic |
|
|
||||||
| Weighted average common shares—diluted |
|
|
||||||
| Cash dividend declared per common share |
$ | |
$ | |
||||
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2019, are an integral part of the condensedconsolidated financial statements.
2
TERADYNE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
| For the Three Months Ended |
||||||||
| March 29, 2020 |
March 31, 2019 |
|||||||
| (in thousands) |
||||||||
| Net income |
$ | |
$ | |
||||
| Other comprehensive income, net of tax: |
||||||||
| Foreign currency translation adjustment, net of tax of $ |
( |
) | ( |
) | ||||
| Available-for-sale marketable securities: |
||||||||
| Unrealized gains on debt securities arising during period, net of tax of $ |
|
|
||||||
| Less: Reclassification adjustment for gains included in net income, net of tax of $( |
( |
) | ( |
) | ||||
| |
|
|||||||
| Defined benefit pension and post-retirement plans: |
||||||||
| Amortization of prior service benefit included in net periodic pension and post-retirement benefit, net of tax of $ |
( |
) | ( |
) | ||||
| Other comprehensive loss |
( |
) | ( |
) | ||||
| Comprehensive income |
$ | |
$ | |
||||
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2019, are an integral part of the condensedconsolidated financial statements.
3
TERADYNE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(Unaudited)
| Common Stock Shares |
Common Stock Par Value |
Additional Paid-in Capital |
Accumulated Other Comprehensive Loss |
Accumulated Deficit |
Total Shareholders’ Equity |
|||||||||||||||||||
| (in thousands) |
||||||||||||||||||||||||
| For the Three Months Ended March 29, 2020 |
||||||||||||||||||||||||
| Balance, December 31, 2019 |
|
$ | |
$ | |
$ | ( |
) | $ | ( |
) | $ | |
|||||||||||
| Net issuance of common stock under stock-based plans |
|
|
( |
) | ( |
) | ||||||||||||||||||
| Stock-based compensation expense |
|
|
||||||||||||||||||||||
| Repurchase of common stock |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
| Cash dividends ($ |
( |
) | ( |
) | ||||||||||||||||||||
| Net income |
|
|
||||||||||||||||||||||
| Other comprehensive loss |
( |
) | ( |
) | ||||||||||||||||||||
| Balance, March 29, 2020 |
|
|
|
( |
) | ( |
) | |
||||||||||||||||
| For the Three Months Ended March 31, 2019 |
||||||||||||||||||||||||
| Balance, December 31, 2018 |
|
$ | |
$ | |
$ | ( |
) | $ | ( |
) | $ | |
|||||||||||
| Net issuance of common stock under stock-based plans |
|
|
( |
) | ( |
) | ||||||||||||||||||
| Stock-based compensation expense |
|
|
||||||||||||||||||||||
| Repurchase of common stock |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
| Cash dividends ($ |
( |
) | ( |
) | ||||||||||||||||||||
| Net income |
|
|
||||||||||||||||||||||
| Other comprehensive loss |
( |
) | ( |
) | ||||||||||||||||||||
| Balance, March 31, 2019 |
|
$ | |
$ | |
$ | ( |
) | $ | ( |
) | $ | |
|||||||||||
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2019, are an integral part of the condensedconsolidated financial statements.
4
TERADYNE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| For the Three Months Ended |
||||||||
| March 29, 2020 |
March 31, 2019 |
|||||||
| (in thousands) |
||||||||
| Cash flows from operating activities: |
||||||||
| Net income |
$ | |
$ | |
||||
| Adjustments to reconcile net income from operations to net cash provided by operating activities: |
||||||||
| Depreciation |
|
|
||||||
| Amortization |
|
|
||||||
| Stock-based compensation |
|
|
||||||
| Provision for excess and obsolete inventory |
|
|
||||||
| Deferred taxes |
( |
) | |
|||||
| Contingent consideration adjustment |
( |
) | |
|||||
| Losses (gains) on investments |
|
( |
) | |||||
| Other |
|
|
||||||
| Changes in operating assets and liabilities, net of businesses acquired: |
||||||||
| Accounts receivable |
( |
) | ( |
) | ||||
| Inventories |
|
( |
) | |||||
| Prepayments and other assets |
( |
) | ( |
) | ||||
| Accounts payable and other liabilities |
( |
) | ( |
) | ||||
| Deferred revenue and customer advances |
( |
) | |
|||||
| Retirement plans contributions |
( |
) | ( |
) | ||||
| Income taxes |
|
( |
) | |||||
| Net cash provided by operating activities |
|
|
||||||
| Cash flows from investing activities: |
||||||||
| Purchases of property, plant and equipment |
( |
) | ( |
) | ||||
| Purchases of marketable securities |
( |
) | ( |
) | ||||
| Proceeds from maturities of marketable securities |
|
|
||||||
| Proceeds from sales of marketable securities |
|
|
||||||
| Acquisition of businesses, net of cash acquired |
|
( |
) | |||||
| Proceeds from life insurance |
— |
|
||||||
| Net cash used for investing activities |
( |
) | ( |
) | ||||
| Cash flows from financing activities: |
||||||||
| Issuance of common stock under stock purchase and stock option plans |
|
|
||||||
| Repurchase of common stock |
( |
) | ( |
) | ||||
| Dividend payments |
( |
) | ( |
) | ||||
| Payments related to net settlement of employee stock compensation awards |
( |
) | ( |
) | ||||
| Payments of contingent consideration |
( |
) | ( |
) | ||||
| Net cash used for financing activities |
( |
) | ( |
) | ||||
| Effects of exchange rate changes on cash and cash equivalents |
|
( |
) | |||||
| Decrease in cash and cash equivalents |
( |
) | ( |
) | ||||
| Cash and cash equivalents at beginning of period |
|
|
||||||
| Cash and cash equivalents at end of period |
$ | |
$ | |
||||
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2019, are an integral part of the condensedconsolidated financial statements.
5
TERADYNE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
A. THE COMPANY
Teradyne, Inc. (“Teradyne”) is a leading global supplier of automation equipment for test and industrial applications. Teradyne designs, develops, manufactures and sells automatic test systems used to test semiconductors, wireless products, data storage and complex electronics systems in the consumer electronics, wireless, automotive, industrial, computing, communications, and aerospace and defense industries. Teradyne’s industrial automation products include collaborative robotic arms, autonomous mobile robots, and advanced robotic control software used by global manufacturing and light industrial customers to improve quality, increase manufacturing and material handling efficiency and decrease manufacturing costs. Teradyne’s automatic test equipment and industrial automation products and services include:
• |
semiconductor test (“Semiconductor Test”) systems; |
• |
defense/aerospace (“Defense/Aerospace”) test instrumentation and systems, storage test (“Storage Test”) systems, and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”); |
• |
industrial automation (“Industrial Automation”) products; and |
• |
wireless test (“Wireless Test”) systems. |
B. ACCOUNTING POLICIES
Basis of Presentation
The consolidated interim financial statements include the accounts of Teradyne and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. Certain prior year amounts were reclassified to conform to the current year presentation. The December 31, 2019 condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.
The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in Teradyne’s Annual Report on Form
10-K,
filed with the U.S. Securities and Exchange Commission (“SEC”) on March 2, 2020, for the year ended December 31, 2019.Preparation of Financial Statements and Use of Estimates
The preparation of consolidated financial statements requires management to make estimates and judgments that affect the amounts reported in the financial statements. Due to the COVID-19 pandemic, there has been uncertainty and disruption in the global economy and our markets. Teradyne is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of May
4
, 2020, the date of issuance of this Quarterly Report on Form 10-Q. These estimates may change, as new events occur and additional information is obtained. Actual results could differ significantly from these estimates under different assumptions or conditions. Goodwill
On January 26, 2017, the Financial Accounting Standards Board (“FASB”) issued ASU The new guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. Teradyne adopted this standard on January 1, 2020, on a prospective basis. The adoption of ASU
2017-04,
“Intangibles—Goodwill and Other (Topic 350): Simplifying the Accounting for Goodwill Impairment.”
2017-04
did not have a material impact on the consolidated statement of operations, cash flows, or earnings per share. Teradyne assesses goodwill for impairment at least annually in the fourth quarter, as of December 31, on a reporting unit basis, or more frequently, when events and circumstances occur indicating that the recorded goodwill may be impaired. Under ASU 2017-04,
goodwill impairment will be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. All other goodwill impairment guidance will remain largely unchanged. Entities will continue to have the option to perform a qualitative assessment to determine if a quantitative impairment test is necessary. The same one-step
impairment test will be applied to goodwill at all reporting units, even those with zero or negative carrying amounts. Entities will be required to disclose the amount of goodwill at reporting units with zero or negative carrying amounts. Credit Losses
In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” This standard introduced the expected credit losses methodology for the measurement of credit losses on financial assets that are not measured at fair value through net income and replaces the “incurred loss” model with an “expected credit loss” model that requires consideration of a broader range of information to estimate expected credit losses over the lifetime of the asset. Teradyne adopted this standard on January 1, 2020 on a modified retrospective basis. The adoption of ASU 2016-13 did not have a material impact on the consolidated statement of operations, balance sheets, cash flows, or earnings per share.
6
C. ACQUISITIONS
AutoGuide LLC
On November 13, 2019, Teradyne acquired 100 % of the membership interests of AutoGuide, LLC (“AutoGuide”), a maker of high-payload autonomous mobile robots (“AMRs”), based in Chelmsford, MA, an emerging and fast growing segment of the global forklift market. The total purchase price was approximately $81.6 million, which included cash paid of approximately $57.6 million and $24.0 million in fair value of contingent consideration payable upon achievement of certain performance targets, extending potentially through 2022. At March 29, 2020, the maximum contingent consideration that could be paid is $106.9 million.
The contingent consideration is payable upon achievement of certain thresholds and targets for revenue and earnings before interest and taxes for periods from January 1, 2019 to December 31, 2020, January 1, 2019 to December 31, 2021, and January 1, 2019 to December 31, 2022.
The valuation of the contingent consideration is dependent on the following assumptions: forecasted revenues, revenue volatility, earnings before interest and taxes, and discount rate. These assumptions were estimated based on a review of the historical and projected results.
The AutoGuide acquisition was accounted for as a business combination and, accordingly, the results have been included in Teradyne’s consolidated results of operations from the date of acquisition. AutoGuide’s AMRs are used for material transport of payloads up to 4,500 kg in manufacturing, warehouse and logistics applications. These products complement MiR’s lower payload products and expand the Industrial Automation segment, which is a key component of Teradyne’s growth strategy.
The allocation of the total purchase price to AutoGuide’s net tangible assets and identifiable intangible assets was based on their estimated fair values as of the acquisition date. The excess of the purchase price over the identifiable intangible assets and net tangible assets in the amount of
$41.2
million was allocated to goodwill, which is deductible for tax purposes. AutoGuide’s results have been included in Teradyne’s Industrial Automation segment from the date of acquisition.
The following table represents the final allocation of the purchase price:
Purchase Price Allocation |
||||
(in thousands) |
||||
Goodwill |
$ | |||
Intangible assets |
||||
Tangible assets acquired and liabilities assumed: |
||||
Other current assets |
||||
Non-current assets |
||||
Accounts payable and current liabilities |
( |
) | ||
Long-term other liabilities |
( |
) | ||
Total purchase price |
$ | |||
Teradyne estimated the fair value of intangible assets using the income approach. Forecasted revenues is the key assumption for estimating the fair value.
Acquired intangible assets are amortized on a straight-line basis over their estimated useful lives. Components of these intangible assets and their estimated useful lives at the acquisition date are as follows:
| Fair Value |
Estimated Useful Life |
|||||||
| (in thousands) |
(in years) |
|||||||
| Developed technology |
$ | |
|
|||||
| Customer relationships |
|
|
||||||
| Trademarks and tradenames |
|
|
||||||
| Backlog |
|
|
||||||
| Total intangible assets |
$ | |
|
|||||
7
The following unaudited pro forma information gives effect to the acquisition of AutoGuide as if the acquisition occurred on January 1, 2018. The unaudited pro forma results are not necessarily indicative of what actually would have occurred had the acquisition been in effect for the periods presented:
| For the Three Months Ended |
||||
| March 31, 2019 |
||||
| (in thousands, except per share amounts) |
||||
| Revenue s |
$ | |
||
| Net income |
$ |
|
||
| Net income per common share: |
||||
| Basic |
$ | |
||
| Diluted |
$ | |
||
Lemsys SA
On January 30, 2019, Teradyne acquired all of the issued and outstanding shares of Lemsys SA (“Lemsys”) for a total purchase price of approximately $9.1 million. Lemsys strengthens Teradyne’s position in the electrification trends of vehicles, solar and wind power, and industrial applications. The Lemsys acquisition was accounted for as a business combination and, accordingly, the results have been included in Teradyne’s Semiconductor Test segment from the date of acquisition. Teradyne’s final allocation of the purchase price was goodwill of $1.4 million, which is not deductible for tax purposes, acquired intangible assets of $4.6 million with an average estimated useful life of , and $3.1 million of net tangible assets. The acquisition was not material to Teradyne’s consolidated financial statements.
8
D. REVENUE
Disaggregation of Revenue
The following table provides information about disaggregated revenue by timing of revenue recognition, primary geographical market, and major product lines.
| Semiconductor Test |
Industrial Automation |
Wireless Test |
Corporate and Other |
Total |
||||||||||||||||||||||||||||||||
| System on a Chip |
Memory |
System Test |
Universal Robots |
Mobile Industrial Robots |
AutoGuide |
|||||||||||||||||||||||||||||||
| (in thousands) |
||||||||||||||||||||||||||||||||||||
| For the Three Months Ended March 29, 2020 (1) |
||||||||||||||||||||||||||||||||||||
| Timing of Revenue Recognition |
||||||||||||||||||||||||||||||||||||
| Point in Time |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||||||||
| Over Time |
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
| Total |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||||||||
| Geographical Market |
||||||||||||||||||||||||||||||||||||
| Asia Pacific |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||||||||
| Americas |
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
| Europe, Middle East and Africa |
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
| Total |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||||||||
| For the Three Months Ended March 31, 2019 (1) |
||||||||||||||||||||||||||||||||||||
| Timing of Revenue Recognition |
||||||||||||||||||||||||||||||||||||
| Point in Time |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | — |
$ | |
$ | ( |
) | $ | |
|||||||||||||||||
| Over Time |
|
|
|
|
— |
— |
|
— |
|
|||||||||||||||||||||||||||
| Total |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | — |
$ | |
$ | ( |
) | $ | |
|||||||||||||||||
| Geographical Market |
||||||||||||||||||||||||||||||||||||
| Asia Pacific |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | — |
$ | |
$ | — |
$ | |
||||||||||||||||||
| Americas |
|
|
|
|
|
— |
|
( |
) | |
||||||||||||||||||||||||||
| Europe, Middle East and Africa |
|
|
|
|
|
— |
|
— |
|
|||||||||||||||||||||||||||
| Total |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | — |
$ | |
$ | ( |
) | $ | |
|||||||||||||||||
(1) |
Includes $ Revenue from Contracts with Customers.” |
Contract Balances
For
the three months ended March 29, 2020 and March 31, 2019,
Teradyne recognized
$
million and $
million, respectively, that was previously included within the deferred revenue and customer advances balances. This revenue primarily relates to undelivered hardware, extended warranties, training, application support, and post contract support. Each of these represents a distinct performance obligation. Teradyne expects to
recognize
%
of the remaining performance obligation in the
next
months,
% in
-
years, and the remainder thereafter.
Accounts Receivable
Teradyne sells certain trade accounts receivables on a 46.8 million and $41.7 million for the three months ended March 29, 2020 and March 31, 2019, respectively. Factoring fees for the sales of receivables were recorded in interest expense and were not material.
non-recourse
basis to third-party financial institutions pursuant to factoring agreements. Teradyne accounts for these transactions as sales of receivables and presents cash proceeds as a cash provided by operating activities in the consolidated statements of cash flows. Total trade accounts receivable sold under the factoring agreements were $9
E
. INVENTORIES Inventories, net consisted of the following at March 29, 2020 and December 31, 2019:
| March 29, |
December 31, |
|||||||
| 2020 |
2019 |
|||||||
| (in thousands) |
||||||||
| Raw material |
$ | |
$ | |
||||
| Work-in-process |
|
|
||||||
| Finished goods |
|
|
||||||
| $ | |
$ | |
|||||
Inventory reserves at March 29, 2020 and December 31, 2019 were $105.3 million and $103.6 million, respectively.
F
. FINANCIAL INSTRUMENTS Cash Equivalents
Teradyne considers all highly liquid investments with maturities of three months or less at the date of acquisition to be cash equivalents.
Marketable Securities
Teradyne’s as Level 1. Contingent consideration is classified as Level 3. The vast majority of Level 2 securities are fixed income securities priced by third party pricing vendors. These pricing vendors utilize the most recent observable market information in pricing these securities or, if specific prices are not available, use other observable inputs like market transactions involving identical or comparable securities.
available-for-sale
debt securities are classified as Level 2 and equity and debt mutual funds are classified
During the three months ended March 29, 2020 and March 31, 2019, there were no transfers in or out of Level 1, Level 2, or Level 3 financial instruments.
Realized gains recorded in the three months ended March 29, 2020 and March 31, 2019 were $1.4 million and $0.1 million, respectively. Realized losses recorded in the three months ended March 29, 2020 and March 31, 2019 were $0.1
million. Realized gains and losses are included in other (income) expense, net.
Unrealized losses on equity securities recorded in the three months ended March 29, 2020 were
million. Unrealized gains on equity securities recorded in the three months ended March 31, 2019 were
Unrealized gains and losses on equity securities are included in other (income) expense, net. Unrealized gains and losses on
available-for-sale
debt securities are included in accumulated other comprehensive income (loss). The cost of securities sold is based on the specific identification method.
10
The following table sets forth by fair value hierarchy Teradyne’s financial assets and liabilities that were measured at fair value on a recurring basis as of March 29, 2020 and December 31, 2019.
| March 29, 2020 |
||||||||||||||||
| Quoted Prices in Active Markets for Identical Instruments (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
Total |
|||||||||||||
| (in thousands) |
||||||||||||||||
| Assets |
||||||||||||||||
| Cash |
$ | |
$ | — |
$ | — |
$ | |
||||||||
| Cash equivalents |
|
|
— |
|
||||||||||||
| Available-for-sale securities: |
||||||||||||||||
| Commercial paper |
— |
|
— |
|
||||||||||||
| U.S. Treasury securities |
— |
|
— |
|
||||||||||||
| Corporate debt securities |
— |
|
— |
|
||||||||||||
| Certificates of deposit and time deposits |
— |
|
— |
|
||||||||||||
| Debt mutual funds |
|
— |
— |
|
||||||||||||
| U.S. government agency securities |
— |
|
— |
|
||||||||||||
| Non-U.S. government securities |
— |
|
— |
|
||||||||||||
| Equity securities: |
||||||||||||||||
| Mutual funds |
|
— |
— |
|
||||||||||||
| $ | |
$ | |
$ | — |
$ | |
|||||||||
| Derivative assets |
— |
|
— |
|
||||||||||||
| Total |
$ | |
$ | |
$ | — |
$ | |
||||||||
| Liabilities |
||||||||||||||||
| Contingent consideration |
$ | — |
$ | — |
$ | |
$ | |
||||||||
| Derivative liabilities |
— |
|
— |
|
||||||||||||
| Total |
$ | — |
$ | |
$ | |
$ | |
||||||||
| Reported as follows: |
|
|
|
|
||||||||||||
| |
(Level 1) |
(Level 2) |
(Level 3) |
Total |
||||||||||||
| (in thousands) |
||||||||||||||||
| Assets |
||||||||||||||||
| Cash and cash equivalents |
$ | |
$ | |
$ | — |
$ | |
||||||||
| Marketable securities |
— |
|
— |
|
||||||||||||
| Long-term marketable securities |
|
|
— |
|
||||||||||||
| Prepayments and other current assets |
— |
|
— |
|
||||||||||||
| Total |
$ | |
$ | |
$ | — |
$ | |
||||||||
| Liabilities |
||||||||||||||||
| Other current liabilities |
$ | — |
$ | |
$ | — |
$ | |
||||||||
| Contingent consideration |
— |
— |
|
|
||||||||||||
| Long-term contingent consideration |
— |
— |
|
|
||||||||||||
| Total |
$ | — |
$ | |
$ | |
$ | |
||||||||
11
| December 31, 2019 |
||||||||||||||||
| Quoted Prices in Active Markets for Identical Instruments (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
Total |
|||||||||||||
| (in thousands) |
||||||||||||||||
| Assets |
||||||||||||||||
| Cash |
$ | |
$ | — |
$ | — |
|
|||||||||
| Cash equivalents |
|
|
— |
|
||||||||||||
| Available-for-sale securities: |
|
|||||||||||||||
| Corporate debt securities |
— |
|
— |
|
||||||||||||
| Commercial paper |
— |
|
— |
|
||||||||||||
| U.S. Treasury securities |
— |
|
— |
|
||||||||||||
| U.S. government agency securities |
— |
|
— |
|
||||||||||||
| Debt mutual funds |
|
— |
— |
|
||||||||||||
| Certificates of deposit and time deposits |
— |
|
— |
|
||||||||||||
| Non-U.S. government securities |
— |
|
— |
|
||||||||||||
| Equity securities: |
||||||||||||||||
| Equity mutual funds |
|
— |
— |
|
||||||||||||
| $ | |
$ | |
$ | — |
$ | |
|||||||||
| Derivative assets |
— |
|
— |
|
||||||||||||
| Total |
$ | |
$ | |
$ | — |
$ | |
||||||||
| Liabilities |
||||||||||||||||
| Contingent consideration |
$ | — |
$ | — |
$ | |
$ | |
||||||||
| Derivative liabilities |
— |
|
— |
|
||||||||||||
| Total |
$ | — |
$ | |
$ | |
$ | |
||||||||
| Reported as follows: |
|
|
|
|
||||||||||||
| |
(Level 1) |
(Level 2) |
(Level 3) |
Total |
||||||||||||
| (in thousands) |
||||||||||||||||
| Assets |
||||||||||||||||
| Cash and cash equivalents |
$ | |
$ | |
$ | — |
$ | |
||||||||
| Marketable securities |
— |
|
— |
|
||||||||||||
| Long-term marketable securities |
|
|
— |
|
||||||||||||
| Prepayments and other current assets |
— |
|
— |
|
||||||||||||
| Total |
$ | |
$ | |
$ | — |
$ | |
||||||||
| Liabilities |
||||||||||||||||
| Other accrued liabilities |
$ | — |
$ | |
$ | — |
$ | |
||||||||
| Contingent consideration |
— |
— |
|
|
||||||||||||
| Long-term contingent consideration |
— |
— |
|
|
||||||||||||
| Total |
$ | — |
$ | |
$ | |
$ | |
||||||||
12
Changes in the fair value of Level 3 contingent consideration for the three months ended March 29, 2020 and March 31, 2019 were as follows:
| For the Three Months Ended |
||||||||
| March 29, |
March 31, |
|||||||
| 2020 |
2019 |
|||||||
| (in thousands) |
||||||||
| Balance at beginning of period |
$ | |
$ | |
||||
| Foreign currency impact |
( |
) | ( |
) | ||||
| Payments (a)(b) |
( |
) | ( |
) | ||||
| Fair value adjustment (c)(d) |
( |
) | |
|||||
| Balance at end of period |
$ | |
$ | |
||||
(a) |
In the three months ended March 29, 2020, Teradyne paid $ earn-out in connection with the acquisition of MiR. |
(b) |
In the three months ended March 31, 2019, Teradyne paid $ |
(c) |
In the three months ended March 29, 2020, the fair value of contingent consideration for the earn-outs in connection with the acquisitions of MiR and AutoGuide decreased by $ |
(d) |
In the three months ended March 31, 2019, the fair value of contingent consideration for the earn-out in connection with the acquisition of MiR increased by $ |
The following table provides quantitative information associated with the fair value measurement of Teradyne’s Level 3 financial instruments:
| Liability |
March 29, 2020 Fair |
Valuation Technique |
Unobservable Inputs |
Weighted Average |
||||||||||||
| (in thousands) |
||||||||||||||||
| Contingent consideration (AutoGuide) |
$ | |
Monte Carlo Simulation |
Revenue volatility |
|
% | ||||||||||
| Discount Rate |
|
% | ||||||||||||||
| Contingent consideration (MiR) |
$ | |
Monte Carlo Simulation |
Revenue volatility |
|
% | ||||||||||
| Discount Rate |
|
% | ||||||||||||||
As of March 29, 2020, the significant unobservable inputs used in the Monte Carlo simulation to fair value the AutoGuide and MiR contingent consideration include forecasted revenues, revenue volatility, earnings before interest and taxes, and discount rate. Increases or decreases in the inputs would result in a higher or lower fair value measurement.
As of March 29, 2020, the maximum amount of contingent consideration that could be paid in connection with the acquisition of AutoGuide is $106.9 million. The 31, 2020, December 31, 2021 and December 31, 2022.
earn-out
periods end on DecemberAs of March 29, 2020, the maximum amount of contingent consideration that could be paid in connection with the acquisition of MiR is $61.4 million. The remaining
earn-out
period ends on December 31, 2020.13
The carrying amounts and fair values of Teradyne’s financial instruments at March 29, 2020 and December 31, 2019 were as follows:
| March 29, 2020 |
December 31, 2019 |
|||||||||||||||
| Carrying Value |
Fair Value |
Carrying Value |
Fair Value |
|||||||||||||
| (in thousands) |
||||||||||||||||
| Assets |
||||||||||||||||
| Cash and cash equivalents |
$ | |
$ | |
$ | |
$ | |
||||||||
| Marketable securities |
|
|
|
|
||||||||||||
| Derivative assets |
|
|
|
|
||||||||||||
| Liabilities |
||||||||||||||||
| Contingent consideration |
|
|
|
|
||||||||||||
| Derivative liabilities |
|
|
|
|
||||||||||||
| Convertible debt (1) |
|
|
|
|
||||||||||||
| (1) | The carrying value represents the bifurcated debt component only, while the fair value is based on quoted market prices for the convertible note, which includes the equity conversion features. |
The fair values of accounts receivable, net and accounts payable approximate the carrying value due to the short-term nature of these instruments.
The following table summarizes the composition of
available-for-sale
marketable securities at March 29, 2020:| March 29, 2020 |
||||||||||||||||||||
| Available-for-Sale |
||||||||||||||||||||
| Cost |
Unrealized Gain |
Unrealized (Loss) |
Fair Market Value |
Fair Market Value of Investments with Unrealized Losses |
||||||||||||||||
| (in thousands) |
||||||||||||||||||||
| Commercial paper |
$ | |
$ | |
$ | ( |
) | $ | |
$ | |
|||||||||
| U.S. Treasury securities |
|
|
( |
) | |
|
||||||||||||||
| Corporate debt securities |
|
|
( |
) | |
|
||||||||||||||
| Certificates of deposit and time deposits |
|
|
— |
|
— |
|||||||||||||||
| Debt mutual funds |
|
|
— |
|
— |
|||||||||||||||
| U.S. government agency securities |
|
|
|
|
|
|||||||||||||||
| Non-U.S. government securities |
|
— |
— |
|
— |
|||||||||||||||
| $ | |
$ | |
$ | ( |
) | $ | |
$ | |
||||||||||
Reported as follows:
| Cost |
Unrealized Gain |
Unrealized (Loss) |
Fair Market Value |
Fair Market Value of Investments with Unrealized Losses |
||||||||||||||||
| (in thousands) |
||||||||||||||||||||
| Marketable securities |
$ | |
$ | |
$ | ( |
) | $ | |
$ | |
|||||||||
| Long-term marketable securities |
|
|
( |
) | |
|
||||||||||||||
| $ | |
$ | |
$ | ( |
) | $ | |
$ | |
||||||||||
14
The following table summarizes the composition of
available-for-sale
marketable securities at December 31, 2019:| December 31, 2019 |
||||||||||||||||||||
| Available-for-Sale |
||||||||||||||||||||
| Cost |
Unrealized Gain |
Unrealized (Loss) |
Fair Market Value |
Fair Market Value of Investments with Unrealized Losses |
||||||||||||||||
| (in thousands) |
||||||||||||||||||||
| Corporate debt securities |
$ | |
$ | |
$ | ( |
) | $ | |
$ | |
|||||||||
| Commercial paper |
|
|
( |
) | |
|
||||||||||||||
| U.S. Treasury securities |
|
|
( |
) | |
|
||||||||||||||
| U.S. government agency securities |
|
|
( |
) | |
|
||||||||||||||
| Debt mutual funds |
|
|
— |
|
— |
|||||||||||||||
| Certificates of deposit and time deposits |
|
— |
— |
|
— |
|||||||||||||||
| Non-U.S. government securities |
|
— |
— |
|
— |
|||||||||||||||
| $ | |
$ | |
$ | ( |
) | $ | |
$ | |
||||||||||
Reported as follows:
Cost |
Unrealized Gain |
Unrealized (Loss) |
Fair Market Value |
Fair Market Value of Investments with Unrealized Losses |
||||||||||||||||
(in thousands) |
||||||||||||||||||||
Marketable securities |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
Long-term marketable securities |
( |
) | ||||||||||||||||||
| $ | $ | $ | ( |
) | $ | $ | ||||||||||||||
As of March 29, 2020 and December 31, 2019, the fair market value of investments with unrealized losses less than one year totaled $42.3 million and $23.6 million, respectively.
Teradyne reviews its investments to identify and evaluate investments that have an indication of possible impairment. Based on this review, Teradyne determined that the unrealized losses related to these investments at March 29, 2020 and December 31, 2019 were not other than temporary.
The contractual maturities of investments in
available-for-sale
securities held at March 29, 2020 were as follows:March 29, 2020 |
||||||||
Cost |
Fair Market Value |
|||||||
(in thousands) |
||||||||
Due within one year |
$ | $ | ||||||
Due after 1 year through 5 years |
||||||||
Due after 5 years through 10 years |
||||||||
Due after 10 years |
||||||||
Total |
$ | $ | ||||||
Contractual maturities of investments in 5.2 million of debt mutual funds as they do not have a contractual maturity date.
available-for-sale
securities held at March 29, 2020 exclude $Derivatives
Teradyne conducts business in a number of foreign countries, with certain transactions denominated in local currencies. The purpose of Teradyne’s foreign currency management is to minimize the effect of exchange rate fluctuations on certain foreign currency denominated monetary assets and liabilities. Teradyne does not use derivative financial instruments for trading or speculative purposes.
15
To minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings, and is used to offset the change in value of monetary assets and liabilities denominated in foreign currencies.
The notional amount of foreign currency forward contracts at March 29, 2020 and December 31, 2019 was $132.1 million and $144.9 million, respectively.
Gains and losses on foreign currency forward contracts and foreign currency remeasurement gains and losses on monetary assets and liabilities are included in other (income) expense, net.
Balance Sheet Location |
March 29, 2020 |
December 31, 2019 |
||||||||||
(in thousands) |
||||||||||||
Derivatives not designated as hedging instruments: |
||||||||||||
Foreign exchange contracts |
Prepayments |
$ | $ | |||||||||
Foreign exchange contracts |
Other current liabilities |
( |
) | ( |
) | |||||||
Total derivatives |
$ | $ | ||||||||||
The following table summarizes the effect of derivative instruments recognized in the statement of operations for the three months ended March 29, 2020 and March 31, 2019:
Location of Losses |
For the Three Months Ended |
| ||||||||
Recognized in |
March 29, |
March 31, |
||||||||
| |
2020 |
2019 |
||||||||
(in thousands) |
||||||||||
Derivatives not designated as hedging instruments: |
||||||||||
Foreign exchange contracts |
Other (income) expense, net |
$ | $ | |||||||
| (1) | The table does not reflect the corresponding gains and losses from the remeasurement of the monetary assets and liabilities denominated in foreign currencies. |
| (2) | For the three months ended March 29, 2020 and March 31, 2019, net gains from the remeasurement of monetary assets and liabilities denominated in foreign currencies were $ |
See Note
G
: “Debt” regarding derivatives related to the convertible senior notes. G
. DEBT Convertible Senior Notes
On December 12, 2016, Teradyne completed a private offering of $460.0 million aggregate principal amount of 1.25 % convertible senior unsecured notes (the “Notes”) due December 15, 2023 and received net proceeds, after issuance costs, of approximately $450.8 million, $33.0 million of which was used to pay the net cost of the convertible note hedge transactions and $50.1 million of which was used to repurchase 2.0 million shares of Teradyne’s common stock under its existing stock repurchase program from purchasers of the Notes in privately negotiated transactions effected through one of the initial purchasers or its affiliates conducted concurrently with the pricing of the Note offering. The Notes will mature on December 15, 2023, unless earlier repurchased or converted. The Notes bear interest from December 12, 2016 at a rate of 1.25% per year payable semiannually in arrears on June 15 and December 15 of each year . The Notes will be convertible at the option of the noteholders at any time prior to the close of business on the business day immediately preceding September 15, 2023 , only under the following circumstances: (1) during any calendar quarter beginning after March 31, 2017 (and only during such calendar quarter), if the closing sale price of Teradyne’s common stock, for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130 % of the conversion price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price (as defined in the Indenture) per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98 %
of the product of the closing sale price of the Teradyne’s common stock and the conversion rate on each such trading day; and (3) upon the occurrence of specified corporate events. On or after September 15, 2023 until the close of business on the second scheduled
16
trading day immediately preceding the maturity date, holders may convert their Notes at any time, regardless of the foregoing circumstances. Teradyne may satisfy its conversion obligation by paying or delivering cash, shares of its common stock or a combination of cash and shares of its common stock, at Teradyne’s election. As of March 29, 2020, the conversion price
was
approximately
$
per share of Teradyne’s common stock. The conversion rate is subject to adjustment under certain circumstances. As of May
4
, 2020, eight holders exercised the option to convert seventeen thousand dollars worth of Notes. Concurrent with the offering of the Notes, Teradyne entered into convertible note hedge transactions (the “Note Hedge Transactions”) with the initial purchasers or their affiliates (the “Option Counterparties”). The Note Hedge Transactions cover, subject to customary anti-dilution adjustments, the number of shares of the common stock that underlie the Notes, with a strike price equal to the conversion price of the Notes of $31.61 . The Note Hedge Transactions cover, subject to customary anti-dilution adjustments, approximately 14.6 million shares of Teradyne’s common stock.
Separately
and concurrent with the pricing of the Notes,
Teradyne entered into warrant transactions with the Option
Counterparties (the “Warrant Transactions”) in which it sold
net-share-settled
(or, at its election subject to certain conditions, cash-settled) warrants to the Option
Counterparties. The Warrant Transactions cover, subject to customary anti-dilution adjustments, approximately 14.6 million shares of common stock. As of March 29, 2020, the strike price of the warrants was approximately $
per share. The strike price is subject to adjustment under certain circumstances. The Warrant Transactions could have a dilutive effect to
Teradyne’s common stock to the extent that the market price per share of
Teradyne’s common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants.
The Note Hedge Transactions are expected to reduce the potential dilution to Teradyne’s common stock upon any conversion of the Notes. However, the Warrant Transactions could separately have a dilutive effect to the extent that the market value per share of Teradyne’s common stock exceeds the applicable strike price of the warrant. The net cost of the Note Hedge Transactions, after being partially offset by the proceeds from the sale of the warrants, was approximately $33.0 million.
In connection with establishing their initial hedge of these convertible note hedge and warrant transactions, the Option Counterparties have entered into various derivative transactions with respect to Teradyne’s common stock and/or purchased shares of Teradyne’s common stock or other securities, including the Notes, concurrent with, or shortly after, the pricing of the Notes. In addition, the Option Counterparties may modify their hedge positions by entering into or unwinding various derivative transactions with respect to Teradyne’s common stock or by selling Teradyne’s common stock or other securities, including the Notes, in secondary market transactions (and may do so during any observation period related to the conversion of the Notes). These activities could adversely affect the value of Teradyne’s common stock and the Notes.
Teradyne considered the guidance of ASC and concluded that the convertible note hedge is both indexed to Teradyne’s common stock and should be classified in stockholders’ equity in its statements of financial position. The convertible note hedge is considered indexed to Teradyne’s common stock as the terms of the Note Hedge Transactions do not contain an exercise contingency and the settlement amount equals the difference between the fair value of a fixed number of Teradyne’s shares and a fixed strike price. Because the only variable that can affect the settlement amount is Teradyne’s stock price, which is an input to the fair value of a
815-40,
“Derivatives and Hedging—Contracts in Entity’s Own Equity,”
fixed-for-fixed
option contract, the convertible note hedge is considered indexed to Teradyne’s common stock.Teradyne assessed whether the convertible note hedge should be classified as equity under ASC
815-40.
In the Note Hedge Transactions contract the settlement terms permit net cash settlement or net share settlement, at the option of Teradyne. Therefore, the criteria as set forth in ASC 815-40
were evaluated by Teradyne. In reviewing the criteria, Teradyne noted the following: (1) the convertible note hedge does not require Teradyne to issue shares; (2) there is no requirement to net cash settle the convertible note hedge for failure to make timely filings with the SEC; (3) in the case of termination, the convertible note hedge is settled in the same consideration as the holders of the underlying stock; (4) the counterparty does not have rights that rank higher than those of a shareholder of the stock underlying the convertible note hedge; and (5) there is no requirement to post collateral. Based on its analysis of those criteria, Teradyne concluded that the convertible note hedge should be recorded in equity and no further adjustment should be made in future periods to adjust the value of the convertible note hedge.Teradyne analyzed the Warrant Transactions under ASC and other relevant literature, and determined that it met the criteria for classification as an equity transaction and is considered indexed to Teradyne’s common stock. As a result, Teradyne recorded the proceeds from the warrants as an increase to additional
815-40,
“Derivatives and Hedging—Contracts in Entity’s Own Equity,”
paid-in
capital. Teradyne does not recognize subsequent changes in fair value of the warrants in its financial statements.The provisions of ASC ” are applicable to the Notes. ASC
470-20,
“Debt with Conversion and Other Options,
470-20
requires Teradyne to separately account for the liability (debt) and equity (conversion feature) components of the Notes in a manner that reflects Teradyne’s nonconvertible debt borrowing rate at the date of issuance when interest cost is recognized in subsequent periods. 17
Teradyne allocated $100.8 million of the $460.0 million principal amount of the Notes to the equity component, which represents a discount to the debt and will be amortized to interest expense using the effective interest method through December 2023. Accordingly, Teradyne’s effective annual interest rate on the Notes will be approximately 5.0 %. The Notes are classified as long-term debt in the balance sheet based on their December 15, 2023 maturity date. Debt issuance costs of approximately $7.2 million are being amortized to interest expense using the effective interest method over the seven-year term of the Notes. As of March 29, 2020, debt issuance costs were approximately $4.1 million.
The below tables represent the key components of Teradyne’s convertible senior notes:
March 29, 2020 |
December 31, 2019 |
|||||||
(in thousands) |
||||||||
Debt Principal |
$ | $ | ||||||
Unamortized discount |
||||||||
Net Carrying amount of convertible debt |
$ | $ | ||||||
For the Three Months Ended |
||||||||
March 29, 2020 |
March 31, 2019 |
|||||||
(in thousands) |
||||||||
Contractual interest expense on the coupon |
$ | $ | ||||||
Amortization of the discount component and debt issue fees recognized as interest expense |
||||||||
Total interest expense on the convertible debt |
$ | $ | ||||||
As of March 29, 2020, the remaining unamortized discount was $61.5 million, which will be amortized over 3.7 years using the effective interest rate method. The carrying amount of the equity component was $100.8 million. As of March 29, 2020, the 798.3 million
if-converted
value of the Notes was $.
H
. PREPAYMENTS Prepayments consist of the following and are included in prepayments and other assets on the balance sheet:
March 29, |
December 31, |
|||||||
2020 |
2019 |
|||||||
(in thousands) |
||||||||
Contract manufacturer and supplier prepayments |
$ | $ | ||||||
Prepaid taxes |
||||||||
Prepaid maintenance and other services |
||||||||
Other prepayments |
||||||||
Total prepayments |
$ | $ | ||||||
I
. DEFERRED REVENUE AND CUSTOMER ADVANCES Deferred revenue and customer advances consist of the following and are included in short and long-term deferred revenue and customer advances on the balance sheet:
March 29, |
December 31, |
|||||||
2020 |
2019 |
|||||||
(in thousands) |
||||||||
Maintenance, se r vice and training |
$ | $ | ||||||
Extended warranty |
||||||||
Customer advances, undelivered elements and other |
||||||||
Total deferred revenue and customer advances |
$ | $ | ||||||
18
J
. PRODUCT WARRANTY Teradyne generally provides a
one-year
warranty on its products, commencing upon installation, acceptance or shipment. A provision is recorded upon revenue recognition to cost of revenues for estimated warranty expense based on historical experience.For the Three Months Ended |
||||||||
March 29, |
March 31, |
|||||||
2020 |
2019 |
|||||||
(in thousands) |
||||||||
Balance at beginning of period |
$ | $ | ||||||
Acquisition |
— |
|||||||
Accruals for warranties issued during the period |
||||||||
Accruals related to pre-existing warranties |
||||||||
Settlements made during the period |
( |
) | ( |
) | ||||
Balance at end of period |
$ | $ | ||||||
When Teradyne receives revenue for extended warranties, beyond one year, it is deferred and recognized on a straight-line basis over the contract period. Related costs are expensed as incurred. The balance below is included in short and long-term deferred revenue and customer advances.
For the Three Months Ended |
||||||||
March 29, |
March 31, |
|||||||
2020 |
2019 |
|||||||
(in thousands) |
||||||||
Balance at beginning of period |
$ | $ | ||||||
Deferral of new extended warranty revenue |
||||||||
Recognition of extended warranty deferred revenue |
( |
) | ( |
) | ||||
Balance at end of period |
$ | $ | ||||||
K
. STOCK-BASED COMPENSATION Under Teradyne’s stock compensation plans, Teradyne grants service-based restricted stock units, performance-based restricted stock units and stock options, and employees are eligible to purchase Teradyne’s common stock through its Employee Stock Purchase Plan (“ESPP”).
Service
-based restricted stock unit awards granted to employees vest in equal annual installments over non-employee
directors vest after a service
-based vesting, which is determined to be the fair market value of the shares at the date of grant, ratably over the period during which the restrictions lapse.Performance-based restricted stock units (“PRSUs”) granted to Teradyne’s executive officers may have a performance metric based on relative total shareholder return (“TSR”). Teradyne’s three-year TSR performance is measured against the New York Stock Exchange (“NYSE”) Composite Index. The final number of TSR PRSUs that vest will vary based upon the level of performance achieved
from 0 % to 200 % of the target shares capped at four times the grant date value for grants prior to 2019 .
The TSR PRSUs will vest upon the three-year anniversary of the grant date. The TSR PRSUs are valued using a Monte Carlo simulation model. The number of units expected to be earned, based upon the achievement of the TSR market condition, is factored into the grant date Monte Carlo valuation. Compensation expense is recognized on a straight-line basis over the shorter of the three-year service period or the period from the grant to the date described in the retirement provisions below. Compensation expense for executive officers meeting the retirement provisions prior to the grant date is recognized during the 365 days following the grant. Compensation expense is recognized regardless of the eventual number of units that are earned based upon the market condition, provided the executive officer remains an employee at the end of the three-year period. Compensation expense is reversed if at any time during the three-year service period the executive officer is no longer an employee, subject to the retirement and termination eligibility provisions noted below.
19
PRSUs granted to Teradyne’s executive officers may also have a performance metric
based
on
cumulative
non-GAAP
profit before interest and tax (“PBIT”) as a percent of
Teradyne’s revenue.
Non-GAAP
PBIT is a financial measure equal to GAAP income from operations less restructuring and other, net; amortization of acquired intangible assets; acquisition and divestiture related charges or credits; pension actuarial gains and losses;
non-cash
convertible debt interest expense; and other
non-recurring
gains and charges. The final number of PBIT PRSUs that vest will vary based upon the level of performance achieved from
% to
% of the target shares.
The PBIT PRSUs will vest upon the three-year anniversary of the grant date. Compensation expense is recognized on a straight-line basis over the shorter of the three-year service period or the period from the grant date to the date described in the retirement provisions below. Compensation expense for executive officers meeting the retirement provisions prior to the grant date is recognized during the 365 days following the grant. Compensation expense is recognized based on the number of units that are earned based upon the three-year Teradyne PBIT as a percent of Teradyne’s revenue, provided the executive officer remains an employee at the end of the three-year period subject to the retirement and termination eligibility provisions noted below.
If a PRSU recipient’s employment ends prior to the determination of the performance percentage due to (1) permanent disability or death or (2) retirement or termination other than for cause, after attaining both at least
age and at least ten years of service, then all or a portion of the recipient’s PRSUs (based on the actual performance percentage achieved on the determination date) will vest on the date the performance percentage is determined. Except as set forth in the preceding sentence, no PRSUs will vest if the executive officer is no longer an employee at the end of the -year period.
Stock options to purchase Teradyne’s common stock at 100 % of the fair market value on the grant date vest in equal annual installments over four years from the grant date and have a maximum term of seven years.
During the three months ended March 29, 2020 and March 31, 2019, Teradyne granted 0.4 million and 0.6 million of service-based restricted stock unit awards to employees at a weighted average grant date fair value of $70.98 and $35.88 , respectively.
During the three months ended March 29, 2020 and March 31, 2019, Teradyne granted 0.1 million of PBIT PRSUs with a grant date fair value of $70.94 and $35.67 , respectively.
During the three months ended March 29, 2020 and March 31, 2019, Teradyne grante
d
million TSR PRSUs, with a grant date fair value of
$
and $
, respectively.
For the Three Months Ended |
||||||||
March 29, |
March 31, |
|||||||
2020 |
2019 |
|||||||
Risk-free interest rate |
% | % | ||||||
Teradyne volatility-historical |
% | % | ||||||
NYSE Composite Index volatility-historical |
% | % | ||||||
Dividend yield |
% | % | ||||||
Expected volatility was based on the historical volatility of Teradyne’s stock and the NYSE Composite Index for the 2020 and 2019 grant over the most recent three-year period. The risk-free interest rate was determined using the U.S. Treasury yield curve in effect at the time of grant. Dividend yield was based upon an estimated annual dividend amount
of $0.40
per share divided by Teradyne’s stock price on the grant date of
$
for the 2020 grant and an estimated annual dividend amount of
$
per share divided by Teradyne’s stock price on the grant date of
$
for the 2019 grant.
During the three months ended March 29, 2020 and March 31, 2019, Teradyne granted 0.1
million of service-based stock options to executive officers at a weighted average grant date fair value of
$
and $
, respectively.
The fair value of stock options was estimated using the Black-Scholes option-pricing model with the following assumptions:
| For the Three Months Ended |
||||||||
| March 29, |
March 31, |
|||||||
| 2020 |
2019 |
|||||||
| Expected life (years) |
|
|
||||||
| Risk-free interest rate |
|
% | |
% | ||||
| Volatility-historical |
|
% | |
% | ||||
| Dividend yield |
|
% | |
% | ||||
20
Teradyne determined the stock options’ expected life based upon historical exercise data for executive officers, the age of the executive officers and the terms of the stock option grant. Volatility was determined using historical volatility for a period equal to the expected life. The risk-free interest rate was determined using the U.S. Treasury yield curve in effect at the time of grant. Dividend yield was based upon an estimated annual dividend amount of $0.40
per share divided by Teradyne’s stock price on the grant date of
$
for the 2020 grant and an estimated annual dividend amount of $0.36 per share divided by Teradyne’s stock price on the grant date of
$
for the 2019 grant.
L. ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME
Changes in accumulated other comprehensive (loss) income, which are presented net of tax, consist of the following:
| Foreign Currency Translation Adjustment |
Unrealized Gains (Losses) on Marketable Securities |
Retirement Plans Prior Service Credit |
Total |
|||||||||||||
| (in thousands) |
||||||||||||||||
| Three Months Ended March 29, 2020 |
||||||||||||||||
| Balance at December 31, 2019, net of tax of $ |
$ | ( |
) | $ | |
$ | |
$ | ( |
) | ||||||
| Other comprehensive income (loss) before reclassifications, net of tax of $ |
( |
) | |
|
( |
) | ||||||||||
| Amounts reclassified from accumulated other comprehensive income, net of tax of $ |
|
( |
) | ( |
) | ( |
) | |||||||||
| Net current period other comprehensive income (loss), net of tax of $ |
( |
) | |
( |
) | ( |
) | |||||||||
| Balance at March 29, 2020, net of tax of $ |
$ | ( |
) | $ | |
$ | |
$ | ( |
) | ||||||
| Three Months Ended March 31 , 2019 |
||||||||||||||||
| Balance at December 31, 2018, net of tax of $ |
$ | ( |
) | $ | ( |
) | $ | |
$ | ( |
) | |||||
| Other comprehensive income (loss) before reclassifications, net of tax of $ |
( |
) | |
|
( |
) | ||||||||||
| Amounts reclassified from accumulated other comprehensive income, net of tax of $ |
|
( |
) | ( |
) | ( |
) | |||||||||
| Net current period other comprehensive income (loss), net of tax of $ |
( |
) | |
( |
) | ( |
) | |||||||||
| Balance as March 31, 2019, net of tax of $ |
$ | ( |
) | $ | |
$ | |
$ | ( |
) | ||||||
Reclassifications out of accumulated other comprehensive (loss) income to the statement of operations for the three months ended March 29, 2020 and March 31, 2019 were as follows:
| |
For the Three Months Ended |
Affected Line Item in the Statements of Operations |
||||||||||
| March 29, |
March 31, |
|||||||||||
| 2020 |
2019 |
|||||||||||
| Details about Accumulated Other Comprehensive ( Income Components loss ) |
(in thousands) |
|||||||||||
| Available-for-sale marketable securities: |
||||||||||||
| Unrealized gains, net of tax of $ |
$ | |
$ | |
Interest income |
|||||||
| Defined benefit pension and postretirement plans: |
||||||||||||
| Amortization of prior service benefit, net of tax of $ |
|
|
(a) |
|||||||||
| Total reclassifications, net of tax of $ |
$ | |
$ | |
Net income |
|||||||
(a) |
The amortization of prior service benefit is included in the computation of net periodic pension cost and postretirement benefit. See Note P: “Retirement Plans.” |
M. GOODWILL AND ACQUIRED INTANGIBLE ASSETS
Goodwill
Teradyne performs its annual goodwill impairment test as required under the provisions of ASC on December 31 of each fiscal year unless interim indicators of impairment exist. Goodwill is considered impaired when the net book value of a reporting unit exceeds its estimated fair value.
350-10,
“Intangibles—Goodwill and Other”
21
The changes in the carrying amount of goodwill by reportable segments for the three months ended March 29, 2020, were as follows:
| Industrial Automation |
System Test |
Wireless Test |
Semiconductor Test |
Total |
||||||||||||||||
| (in thousands) |
||||||||||||||||||||
| Balance at December 31, 2019 |
||||||||||||||||||||
| Goodwill |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||
| Accumulated impairment losses |
— |
( |
) | ( |
) | ( |
) | ( |
) | |||||||||||
| |
|
|
|
|
||||||||||||||||
| AutoGuide acquisition |
( |
) | — |
— |
— |
( |
) | |||||||||||||
| Foreign currency translation adjustment |
( |
) | — |
— |
|
( |
) | |||||||||||||
| Balance at March 29, 2020 |
||||||||||||||||||||
| Goodwill |
|
|
|
|
|
|||||||||||||||
| Accumulated impairment losses |
— |
( |
) | ( |
) | ( |
) | ( |
) | |||||||||||
| $ | |
$ | |
$ | |
$ | |
$ | |
|||||||||||
Intangible Assets
Teradyne reviews long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate.
Amortizable intangible assets consist of the following and are included in intangible assets, net on the balance sheet:
| Gross Carrying Amount |
Accumulated Amortization |
Foreign Currency Translation Adjustment |
Net Carrying Amount |
|||||||||||||
| (in thousands) |
||||||||||||||||
| Balance, March 29, 2020 |
||||||||||||||||
| Developed technology |
$ | |
$ | ( |
) | $ | ( |
) | $ | |
||||||
| Customer relationships |
|
( |
) | ( |
) | |
||||||||||
| Tradenames and trademarks |
|
( |
) | ( |
) | |
||||||||||
| Backlog |
|
( |
) | — |
— |
|||||||||||
| Total intangible assets |
$ | |
$ | ( |
) | $ | ( |
) | $ | |
||||||
| Balance, December 31, 2019 |
||||||||||||||||
| Developed technology |
$ | |
$ | ( |
) | $ | ( |
) | $ | |
||||||
| Customer relationships |
|
( |
) | ( |
) | |
||||||||||
| Tradenames and trademarks |
|
( |
) | ( |
) | |
||||||||||
| Backlog |
|
( |
) | — |
— |
|||||||||||
| Total intangible assets |
$ | |
$ | ( |
) | $ | ( |
) | $ | |
||||||
Aggregate intangible asset amortization expense for the three months ended March 29, 2020 and March 31, 2019
was $9.9 million and $10.6 million, respectively.
Estimated intangible asset amortization expense for each of the five succeeding fiscal years is as follows:
| Amortization Expense |
||||
Year |
(in thousands) |
|||
| 2020 (remainder) |
|
|||
| 2021 |
|
|||
| 2022 |
|
|||
| 2023 |
|
|||
| 2024 |
|
|||
| Thereafter |
|
|||
22
N
. NET INCOME PER COMMON SHARE The following table sets forth the computation of basic and diluted net income per common share:
| For the Three Months Ended |
||||||||
| March 29, |
March 31, |
|||||||
| 2020 |
2019 |
|||||||
| (in thousands, except per share amounts) |
||||||||
| Net income for basic and diluted net income per share |
$ | |
$ | |
||||
| Weighted average common shares-basic |
|
|
||||||
| Effect of dilutive potential common shares: |
||||||||
| Incremental shares from assumed conversion of convertible notes (1) |
|
|
||||||
| Convertible note hedge warrant shares (2) |
|
— |
||||||
| Restricted stock units |
|
|
||||||
| Stock options |
|
|
||||||
| Employee stock purchase plan |
|
|
||||||
| Dilutive potential common shares |
|
|
||||||
| Weighted average common shares-diluted |
|
|
||||||
| Net income per common share-basic |
$ | |
$ | |
||||
| Net income per common share-diluted |
$ | |
$ | |
||||
| (1) | Incremental shares from assumed conversion of the convertible notes was calculated using the difference between the average Teradyne stock price for the period and the conversion price of $ |
| (2) | Convertible notes hedge warrant shares were calculated using the difference between the average Teradyne stock price for the period and the warrant price of $ |
The computation of diluted net income per common share for the three months ended March 29, 2020 excludes the effect of the potential vesting of 0.3 million of restricted stock units because the effect would have been anti-dilutive.
The computation of diluted net income per common share for the three months ended March 0.6 million shares of restricted stock units because the effect would have been anti-dilutive.
31
, 2019
excludes the effect of the potential vesting of O
. RESTRUCTURING AND OTHER During the three months ended March 29, 2020,
Teradyne recorded a
gain
of $10.0
million for the decrease in the fair value of the AutoGuide and MiR contingent consideration liabilit
i
es
, partially offset by $1.4
million of acquisition related compensation and expenses
and
$0.7
million of severance charges related to headcount reductions primarily in Industrial Automation and Semiconductor Test.
During the three months ended March 31, 2019, Teradyne recorded an expense of $3.0 million for the increase in the fair value of the MiR contingent consideration liability, $1.3 million of acquisition related compensation and expenses0.8 million of severance charges related to headcount reductions primarily in Semiconductor Test.
,
and $P
. RETIREMENT PLANS ASC 715,
“Compensation—Retirement Benefits”
requires an employer with a defined benefit plan or other postretirement benefit plan to recognize an asset or a liability on its balance sheet for the overfunded or underfunded status of the plan. The pension asset or liability represents a difference between the fair value of the pension plan’s assets and the projected benefit obligation at December 31. Teradyne uses a December 31 measurement date for all of its plans.
Defined Benefit Pension Plans
Teradyne has defined benefit pension plans covering a portion of domestic employees and employees of certain
non-U.S.
subsidiaries. Benefits under these plans are based on employees’ years of service and compensation. Teradyne’s funding policy is to make contributions to these plans in accordance with local laws and to the extent that such contributions are tax deductible. The assets23
of the U.S. qualified pension plan consist primarily of fixed income and equity securities. In addition, Teradyne has unfunded qualified foreign plans as well as an unfunded supplemental executive defined benefit plan in the United States to provide retirement benefits in excess of levels allowed by the Employment Retirement Income Security Act (“ERISA”) and the Internal Revenue Code (“IRC”).
In the three months ended March 29, 2020, Teradyne contributed $0.7 million to the U.S. supplemental executive defined benefit pension plan and $0.2 million to certain qualified pension plans for
non-U.S.
subsidiaries.For the three months ended March 29, 2020 and March 31, 2019, Teradyne’s net periodic pension cost was comprised of the following:
| For the Three Months Ended |
||||||||||||||||
| March 29, 2020 |
March 31, 2019 |
|||||||||||||||
| United States |
Foreign |
United States |
Foreign |
|||||||||||||
| (in thousands) |
||||||||||||||||
| Service cost |
$ | |
$ | |
$ | |
$ | |
||||||||
| Interest cost |
|
|
|
|
||||||||||||
| Expected return on plan assets |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Total net periodic pension cost |
$ | |
$ | |
$ | |
$ | |
||||||||
Postretirement Benefit Plan
In addition to receiving pension benefits, Teradyne employees in the United States who meet early retirement eligibility requirements as of their termination dates may participate in Teradyne’s Welfare Plan, which includes medical and dental benefits up to age 65. Death benefits provide a fixed sum to retirees’ survivors and are available to all retirees. Substantially all of Teradyne’s current U.S. employees could become eligible for these benefits, and the existing benefit obligation relates primarily to those employees.
For the three months ended March 29, 2020 and March 31, 2019, Teradyne’s net periodic postretirement benefit cost was comprised of the following:
| For the Three Months Ended |
||||||||
| March 29, |
March 31, |
|||||||
| 2020 |
2019 |
|||||||
| (in thousands) |
||||||||
| Service cost |
$ |
|
$ |
|
||||
| Interest cost |
|
|
||||||
| Amortization of prior service credit |
( |
) |
( |
) | ||||
| Total net periodic postretirement benefit cost |
$ |
|
$ |
|
||||
Q
. COMMITMENTS AND CONTINGENCIES Purchase Commitments
As of March 29, 2020, Teradyne had entered into purchase commitments for certain components and materials. The purchase commitments covered by the agreements aggregate to approximately $543.8 million, of which $529.4 million is for less than one year.
Legal Claims
Teradyne is subject to various legal proceedings and claims which have arisen in the ordinary course of business such as, but not limited to, patent, employment, commercial and environmental matters. Teradyne believes that it has meritorious defenses against all pending claims and intends to vigorously contest them. While it is not possible to predict or determine the outcomes of any pending claims or to provide possible ranges of losses that may arise, Teradyne believes the potential losses associated with all of these actions are unlikely to have a material adverse effect on its business, financial position or results of operations.
24
R
. INCOME TAXES A reconciliation of the United States federal statutory corporate tax rate to Teradyne’s effective tax rate was as follows:
| For the Three Months Ended |
||||||||
| March 29, |
March 31, |
|||||||
| 2020 |
2019 |
|||||||
| US statutory federal tax rate |
|
% |
|
% | ||||
| Foreign taxes |
( |
) |
( |
) | ||||
| Tax credits |
( |
) |
( |
) | ||||
| Discrete benefit related to equity compensation |
( |
) |
( |
) | ||||
| Discrete benefit related to release of reserves for uncertain tax positions |
|
( |
) | |||||
| Other, net |
|
|
||||||
| Effective tax rate |
|
% |
( |
)% | ||||
On a quarterly basis, Teradyne evaluates the realizability of the deferred tax assets by jurisdiction and assesses the need for a valuation allowance. As of March 29, 2020, Teradyne believes that it will ultimately realize the deferred tax assets recorded on the condensed consolidated balance sheet. However, should Teradyne believe that it is
more-likely-than-not
that the deferred tax assets would not be realized, the tax provision would increase in the period in which Teradyne determined that the realizability was not likely. Teradyne considers the probability of future taxable income and historical profitability, among other factors, in assessing the realizability of the deferred tax assets. As of March 29, 2020 and December 31, 2019, Teradyne had $21.3 million and $21.2 million, respectively, of reserves for uncertain tax positions. The $0.1 million net increase in reserves for uncertain tax positions is associated with U.S. research and development tax credits generated in the current year.
As of March 29, 2020, Teradyne does not anticipate a material change in the balance of unrecognized tax benefits during the next twelve months.
Teradyne recognizes interest and penalties related to income tax matters in income tax expense. As of March 29, 2020 and December 31, 2019, $1.6 million and $1.4 million, respectively, of interest and penalties were accrued for uncertain tax positions. For the three months ended March 29, 2020 and March 31, 2019, expense of $0.1 million and $0.3 million, respectively, was recorded for interest and penalties related to income tax items.
Teradyne qualifies for a tax holiday in Singapore by fulfilling the requirements of an agreement with the Singapore Economic Development Board under which certain headcount and spending requirements must be met. The tax savings due to the tax holiday for the three months ended March 29, 2020 was $7.1 million, or $0.04 per diluted share. The tax savings due to the tax holiday for the three months ended March 31, 2019 was $2.1 million, or $0.01 per diluted share. The tax holiday is scheduled to expire on December 31, 2020.
S
Teradyne has four reportable segments (Semiconductor Test, System Test, Industrial Automation and Wireless Test). Each of the Semiconductor Test, System Test, and Wireless Test segments is also an individual operating segment. The Industrial Automation reportable segment consists of operating segments with discrete financial information, which have been combined into one reportable segment as they share similar economic characteristics, types of products, production processes, distribution channels, and currency risks. The Semiconductor Test segment includes operations related to the design, manufacturing and marketing of semiconductor test products and services. The System Test segment includes operations related to the design, manufacturing and marketing of products and services for defense/aerospace instrumentation test, storage test and circuit-board test. The Industrial Automation segment includes operations related to the design, manufacturing and marketing of collaborative robotic arms, autonomous mobile robots and advanced robotic control software. The Wireless Test segment includes operations related to the design, manufacturing and marketing of wireless test products and services.
Teradyne evaluates performance based on several factors, of which the primary financial measure is business segment income (loss) before income taxes. The accounting policies of the business segments in effect are described in Note B: “Accounting Policies” in Teradyne’s Annual Report on Form
10-K
for the year ended December 31, 2019. 25
Segment information for the three months ended March 29, 2020 and March 31, 2019 is as follows:
| Semiconductor Test |
System Test |
Industrial Automation |
Wireless Test |
Corporate and Other |
Consolidated |
|||||||||||||||||||
| (in thousands) |
||||||||||||||||||||||||
| Three Months Ended March 29, 2020 |
||||||||||||||||||||||||
| Revenues |
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||
| Income (loss) before taxes (1)(2) |
|
|
( |
) |
|
( |
) |
|
||||||||||||||||
| Total assets (3) |
|
|
|
|
|
|
||||||||||||||||||
| Three Months Ended March 31, 2019 |
||||||||||||||||||||||||
| Revenues |
$ |
|
$ |
|
$ |
|
$ |
|
$ |
( |
) |
$ |
|
|||||||||||
| Income ( before taxes (1)(2) loss ) |
|
|
( |
) |
|
( |
) |
|
||||||||||||||||
| Total assets (3) |
|
|
|
|
|
|
||||||||||||||||||
(1) |
Included in Corporate and Other are: contingent consideration adjustments, severance charges, interest income, interest expense, net foreign exchange gains (losses), intercompany eliminations and acquisition related charges. |
(2) |
Included in income (loss) before taxes are charges and credits related to restructuring and other, and inventory charges. |
(3) |
Total assets are attributable to each segment. Corporate assets consist of cash and cash equivalents, marketable securities and certain other assets. |
Included in each segment are charges and credits in the following line items in the statements of operations:
| For the Three Months Ended |
||||||||
| March 29, |
March 31, |
|||||||
| 2020 |
2019 |
|||||||
| (in thousands) |
||||||||
| Semiconductor Test: |
||||||||
| Cost of revenues—inventory charge |
$ |
|
$ |
|
||||
| Industrial Automation: |
||||||||
| Restructuring and other—acquisition related expenses and compensation |
|
|
||||||
| Corporate and Other: |
||||||||
| Restructuring and other—MiR contingent consideration adjustment |
( |
) |
|
|||||
| Restructuring and other—AutoGuide contingent consideration adjustment |
( |
) |
|
|||||
| Restructuring and other—acquisition related expenses and compensation |
|
|
||||||
T
. SHAREHOLDERS’ EQUITY Stock Repurchase Program
In January 2020, Teradyne’s Board of Directors authorized a new stock repurchase program for up to $1.0
billion of common stock. Effective April 1, 2020, Teradyne suspended its share repurchase program.
During the three months ended March 29, 2020, Teradyne repurchased 1.3 million shares of common stock for $79.0 million at an average price of $58.81 per share. During the three months ended March 31, 2019, Teradyne repurchased 4.5 million shares of common stock for $156.5 million at an average price of $35.12 per share.
The total price includes commissions and is recorded as a reduction to retained earnings.
Dividend
Holders of Teradyne’s common stock are entitled to receive dividends when they are declared by Teradyne’s Board of Directors.
In January 2020, Teradyne’s Board of Directors declared a quarterly cash dividend of $0.10 per share. Dividend payments for the three months ended March 29, 2020 were $16.7 million.
In January 2019, Teradyne’s Board of Directors declared a quarterly cash dividend of $0.09 per share. Dividend payments for the three months ended March 31, 2019 were $15.6 million.
26
U. SUBSEQUENT EVENT
On May 1, 2020, Teradyne entered into a credit agreement (the “Credit Agreement”) with Truist Bank, as administrative agent and collateral agent, and the lenders party thereto. The Credit Agreement provides for a -year, senior secured revolving credit facility of $400.0 million (the “Credit Facility”). The Credit Agreement further provides that, subject to customary conditions, Teradyne may seek to obtain from existing or new lenders incremental commitments under the Credit Facility in an aggregate principal amount not to exceed $150.0 million.
Proceeds from the Credit Facility may be used for general corporate purposes and working capital. As of May
4
, 2020, Teradyne has not borrowed any funds under the Credit Facility. Teradyne is not required to repay any loans under the Credit Facility prior to maturity, subject to certain customary exceptions. Teradyne is permitted to prepay all or any portion of the loans under the Credit Facility prior to maturity without premium or penalty, other than customary LIBOR breakage costs.
The Credit Agreement contains customary events of default, representations, warranties and affirmative and negative covenants that, among other things, limit Teradyne’s ability to sell assets, grant liens on assets, incur other secured indebtedness and make certain investments and restricted payments, all subject to exceptions set forth in the Credit Agreement. The Credit Agreement also requires Teradyne to satisfy two financial ratios measured as of the end of each fiscal quarter: a consolidated leverage ratio and an interest coverage ratio.
The Credit Facility is guaranteed by certain of Teradyne’s domestic subsidiaries and collateralized by assets of Teradyne and such subsidiaries, including a pledge of 65 % of the capital stock of certain foreign subsidiaries.
Item 2: |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
Statements in this Quarterly Report on Form
10-Q
which are not historical facts, so called “forward-looking statements,” are made pursuant to the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those detailed in our filings with the Securities and Exchange Commission. See also Part II, Item 1A of this Quarterly Report on Form 10-Q
and Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K
for the year ended December 31, 2019. Readers are cautioned not to place undue reliance on these forward-looking statements which reflect management’s analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law. Overview
We are a leading global supplier of automation equipment for test and industrial applications. We design, develop, manufacture and sell automatic test systems used to test semiconductors, wireless products, data storage and complex electronics systems in the consumer electronics, wireless, automotive, industrial, computing, communications, and aerospace and defense industries. Our industrial automation products include collaborative robotic arms, autonomous mobile robots and advanced robotic control software used by global manufacturing and light industrial customers to improve quality, increase manufacturing and material handling efficiency and decrease manufacturing costs. Our automatic test equipment and industrial automation products and services include:
• |
semiconductor test (“Semiconductor Test”) systems; |
• |
defense/aerospace (“Defense/Aerospace”) test instrumentation and systems, storage test (“Storage Test”) systems, and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”); |
27
| • | industrial automation (“Industrial Automation”) products; and |
| • | wireless test (“Wireless Test”) systems. |
We have a customer base which includes integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), original equipment manufacturers (“OEMs”), wafer foundries, fabless companies that design, but contract with others for the manufacture of integrated circuits (“ICs”), developers of wireless devices and consumer electronics, manufacturers of circuit boards, automotive suppliers, wireless product manufacturers, storage device manufacturers, aerospace and military contractors, and distributors that sell collaborative robots, autonomous mobile robots and wireless test systems.
The sales of our products and services are dependent, to a large degree, on these customers who are subject to cyclical trends in the demand for their products. These cyclical periods have had, and will continue to have, a significant effect on our business because our customers often delay or accelerate purchases in reaction to changes in their businesses and to demand fluctuations in the semiconductor, electronics and industrial automation industries. Historically, these demand fluctuations have resulted in significant variations in our results of operations.
The market for our test products is concentrated with a limited number of significant customers accounting for a substantial portion of the purchases of test equipment. A few customers drive significant demand for our products both through direct sales and sales to the customers’ supply partners. We expect that sales of our test products will continue to be concentrated with a limited number of significant customers for the foreseeable future.
On January 30, 2019, we acquired all of the issued and outstanding shares of Lemsys SA (“Lemsys”) for a total purchase price of approximately $9.1 million. Lemsys strengthens our position in the electrification trends of vehicles, solar, wind, and industrial applications. Lemsys is included in our Semiconductor Test segment.
On November 13, 2019, we acquired 100% of the membership interests of AutoGuide, LLC (“AutoGuide”), a maker of high payload AMRs, an emerging and fast growing segment of the global forklift market. The total purchase price was approximately $81.6 million, which included cash paid of approximately $57.6 million and $24.0 million in fair value of contingent consideration payable upon achievement of certain performance targets, extending potentially through 2022. The maximum contingent consideration that could be paid is $106.9 million. AutoGuide’s AMRs are used for material transport of payloads up to 4,500 kg in manufacturing, warehouse and logistics applications. These products complement MiR’s lower payload products. AutoGuide is included in our Industrial Automation segment.
We believe our recent acquisitions have enhanced our opportunities for growth. We intend to continue to invest in our business, grow market share in our markets and expand further our addressable markets while tightly managing our costs.
Impact of the COVID-19 Pandemic on our Business
The novel coronavirus (COVID-19) pandemic has resulted in government authorities implementing numerous measures in an effort to contain the spread of the virus, such as travel bans and restrictions, limitations on gatherings or social distancing requirements, quarantines, shelter-in-place orders, and business limitations and shutdowns. These measures have impacted our day-to-day operations and could disrupt our business, workforce and operations, as well as the operations of our customers, contract manufacturers and suppliers for an uncertain period of time. We are continuing to monitor the rapidly evolving situation regarding the COVID-19 pandemic and its impact on our business, results of operations, financial condition, liquidity and cash flows. However, despite careful tracking, we are unable to accurately predict the full impact of COVID-19, which will depend on future developments that are highly uncertain and cannot be predicted with accuracy, including, but not limited to, the duration and continued spread of the outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume.
Health and Safety
In response to the COVID-19 pandemic, we have taken proactive, aggressive action to protect the health and safety of our employees, customers, contract manufacturers and suppliers and we have complied with all government orders around the globe. The spread of COVID-19 has caused us to modify our business practices, including implementing social distancing protocols, suspending employee travel, requiring most employees to work remotely, cancelling physical participation in meetings, and extensively and frequently disinfecting our workspaces. Around the world, the majority of our employees are working from home. However, some of our engineering, operations, supply line and customer support teams must be on-site at our or our customers’ facilities. We are providing those on-site employees with the necessary protective resources and procedures to minimize their exposure risk. We may take further actions as may be required or recommended by government authorities or that we determine are in the best interests of our employees, customers, contract manufacturers and suppliers.
28
Operations
We believe the COVID-19 pandemic, and the numerous measures implemented by authorities in response, has adversely impacted our results of operations, including by increasing costs and decreasing demand in our Industrial Automation businesses, but we cannot accurately estimate the amount of the impact to our first quarter 2020 financial results or to our future financial results. In addition, restrictions on our access to manufacturing facilities or on our support operations or workforce, or similar limitations for our contract manufacturers and suppliers, and restrictions or disruptions affecting transportation, such as reduced availability of transportation and increased border controls or closures, could limit our capacity to meet customer demand which could have a material adverse effect on our financial condition and results of operations. These measures have impacted and may further impact our workforce and operations, as well as those of our customers, contract manufacturers and suppliers. The constraints and limits imposed on our operations may slow or diminish our production and research and development activities as well as application support projects with our customers. At this time, application support projects are largely on track with employees assisting customers on-site where necessary but with the use of enhanced safety protocols. Research and development projects are, with minor exceptions, on schedule despite the rapid shift of a significant number of our engineers working remotely. While governmental measures may be modified or extended, we expect that our manufacturing and research and development facilities will remain operational, at sufficient capacity to support production demand. We are monitoring our operations closely in an effort to avoid any potential productivity loss caused by responses to the COVID-19 pandemic.
Supply
We have not yet experienced any significant impacts or interruptions to our supply chain as a result of the COVID-19 pandemic. However, our suppliers have faced and may continue to face difficulties maintaining operations in light of government-ordered restrictions, including social distancing requirements and shelter-in-place mandates. Our supply chain team, and our suppliers, overcame numerous supply, production, and logistics obstacles during the first quarter, but there is no assurance we or they will be able to do so in the future. Although we regularly monitor the financial health of companies in our supply chain, financial hardship on our suppliers or sub-suppliers caused by the COVID-19 pandemic could disrupt our ability to obtain components required to manufacture our products, adversely affecting our operations. To mitigate the risk of any potential supply interruptions, we may choose to increase certain inventory levels during the quarter. Additionally, restrictions or disruptions affecting transportation, such as reduced availability of air transport, port closures and increased border controls or closures, have led in some instances to higher costs and delays, both for obtaining components and shipping finished goods to customers, which could harm our profitability, make our products less competitive, or cause our customers to seek alternative suppliers.
Demand
The COVID-19 pandemic has significantly increased economic uncertainty in our markets, which could result in a significant decrease in demand for our products for an uncertain period of time. Demand for our Test products was strong throughout the first quarter and into the second quarter. While there is incremental softening in the automotive sector, there is strengthening demand in mobility, 5G, and memory test. Our Industrial Automation business, however, has seen a significant decline in demand, which we expect will continue in the second quarter, due to COVID-19 related shutdowns affecting global manufacturing. We anticipate that the COVID-19 pandemic could cause further global economic disruption that could cause demand for our products to decline, which would adversely affect our business.
Liquidity
Although there is uncertainty related to the anticipated impact of the COVID-19 pandemic on our future results, we believe our business model, our current cash reserves and the recent steps we have taken to manage our cash flow, such as suspending our stock repurchase program, leave us well-positioned to manage our business through this crisis as it continues to unfold. We have a strong balance sheet as well as an operating model that can flex up and down with extreme demand swings and still remain profitable. Based on our analysis, we believe our existing balances of cash and cash equivalents and our currently anticipated operating cash flows will be sufficient to meet our working capital needs and other capital and liquidity requirements for the next twelve months. However, due to the uncertainty related to the future impact of the COVID-19 pandemic, in order to bolster our liquidity position, on May 1, 2020 we entered into a credit agreement providing for a three-year, senior secured revolving credit facility of $400 million as further described in Note U: “Subsequent Event.” As of May 4, 2020, we have not borrowed any funds under the credit facility. While test demand remained strong at the beginning of our second quarter and our balance sheet has over $900 million in available cash with no short-term debt as of May 4, 2020, the impact of the COVID-19 pandemic on short-term Test and Industrial Automation demand remain uncertain.
We are continuing to monitor the rapidly evolving situation regarding the COVID-19 pandemic and guidance from government authorities around the world, including federal, state and local public health authorities and may take additional actions based on their recommendations. In these circumstances, there may be developments outside our control requiring us to adjust our operating plan. As a result, given the uncertain nature of this situation, we are not able to accurately predict the full extent of the impact of COVID-19 on our business, financial condition, results of operations, liquidity or cash flows in the future. In addition, see Part II—Item 1A, “Risk Factors,” included herein for updates to our risk factors regarding risks associated with the COVID-19 pandemic.
29
Critical Accounting Policies and Estimates
We have identified the policies which are critical to understanding our business and our results of operations. There have been no significant changes during the three months ended March 29, 2020 to the items disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form
10-K
for the fiscal year ended December 31, 2019, except as noted below.Due to the
COVID-19
pandemic, there has been uncertainty and disruption in the global economy and our markets. We are not aware of any specific event or circumstance that would require an update to our estimates or judgments or a revision of the carrying value of our assets or liabilities as of May 4, 2020, the date of issuance of this Quarterly Report on Form 10-Q.
These estimates may change, as new events occur and additional information is obtained. Actual results could differ significantly from these estimates under different assumptions or conditions.Goodwill
On January 26, 2017, the Financial Accounting Standards Board (“FASB”) issued ASU The new guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. We adopted this standard on January 1, 2020, on prospective basis. The adoption of ASU
2017-04,
“Intangibles—Goodwill and Other (Topic 350): Simplifying the Accounting for Goodwill Impairment.”
2017-04
did not have a material impact on the consolidated statement of operations, cash flows, or earnings per share. We assess goodwill for impairment at least annually in the fourth quarter, as of December 31, on a reporting unit basis, or more frequently, when events and circumstances occur indicating that the recorded goodwill may be impaired. Under ASU 2017-04,
goodwill impairment will be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. All other goodwill impairment guidance will remain largely unchanged. Entities will continue to have the option to perform a qualitative assessment to determine if a quantitative impairment test is necessary. The same one-step
impairment test will be applied to goodwill at all reporting units, even those with zero or negative carrying amounts. Entities will be required to disclose the amount of goodwill at reporting units with zero or negative carrying amounts.Credit Losses
In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” This standard introduced the expected credit losses methodology for the measurement of credit losses on financial assets that are not measured at fair value through net income and replaces the “incurred loss” model with an “expected credit loss” model that requires consideration of a broader range of information to estimate expected credit losses over the lifetime of the asset. We adopted this standard on January 1, 2020 on a modified retrospective basis. The adoption of ASU 2016-13 did not have a material impact on our consolidated statement of operations, balance sheets, cash flows, or earnings per share.
Preparation of Financial Statements and Use of Estimates
The preparation of consolidated financial statements requires management to make estimates and judgments that affect the amounts reported in the financial statements. Due to the COVID-19 pandemic, there has been uncertainty and disruption in the global economy and our markets. Teradyne is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of May 4, 2020, the date of issuance of this Quarterly Report on Form 10-Q. These estimates may change, as new events occur and additional information is obtained. Actual results may differ significantly from these estimates under different assumptions or conditions.
30
SELECTED RELATIONSHIPS WITHIN THE CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS
| For the Three Months Ended |
||||||||
| March 29, |
March 31, |
|||||||
| 2020 |
2019 |
|||||||
| Percentage of revenues: |
||||||||
| Revenues: |
||||||||
| Products |
87 |
% | 80 |
% | ||||
| Services |
13 |
20 |
||||||
| Total revenues |
100 |
100 |
||||||
| Cost of revenues: |
||||||||
| Cost of products |
37 |
33 |
||||||
| Cost of services |
6 |
8 |
||||||
| Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below) |
42 |
42 |
||||||
| Gross profit |
58 |
58 |
||||||
| Operating expenses: |
||||||||
| Selling and administrative |
16 |
21 |
||||||
| Engineering and development |
12 |
16 |
||||||
| Acquired intangible assets amortization |
1 |
2 |
||||||
| Restructuring and other |
(1 |
) | 1 |
|||||
| Total operating expenses |
28 |
39 |
||||||
| Income from operations |
29 |
19 |
||||||
| Non-operating (income) expense: |
||||||||
| Interest income |
— |
(1 |
) | |||||
| Interest expense |
1 |
1 |
||||||
| Other (income) expense, net |
1 |
— |
||||||
| Income before income taxes |
28 |
19 |
||||||
| Income tax provision (benefit) |
3 |
(3 |
) | |||||
| Net income |
25 |
% | 22 |
% | ||||
Results of Operations
First Quarter 2020 Compared to First Quarter 2019
Revenues
Revenues by our four reportable segments were as follows:
| For the Three Months Ended |
||||||||||||
| March 29, |
March 31, |
Dollar |
||||||||||
| 2020 |
2019 |
Change |
||||||||||
| (in millions) |
||||||||||||
| Semiconductor Test |
$ | 484.5 |
$ | 340.9 |
$ | 143.6 |
||||||
| System Test |
116.1 |
58.2 |
57.9 |
|||||||||
| Industrial Automation |
60.3 |
66.1 |
(5.8 |
) | ||||||||
| Wireless Test |
43.5 |
29.0 |
14.5 |
|||||||||
| $ | 704.4 |
$ | 494.1 |
$ | 210.3 |
|||||||
The increase in Semiconductor Test revenues of $143.6 million, or 42.1%, was driven primarily by an increase in semiconductor mobility tester sales resulting from increased complexity of silicon in handsets which drives demand for testers, and an increase in memory test sales of flash and DRAM memory testers. The increase in System Test revenues of $57.9 million, or 99.5%, was primarily due to higher sales in Storage Test of 3.5” hard disk drive and system level testers, and higher sales in Defense/Aerospace
31
test instrumentation and systems, partially offset by lower sales in Production Board Test due to lower automotive electronics demand. The decrease in Industrial Automation revenues of $5.8 million, or 8.8%, was primarily due to lower demand for collaborative robotic arms in automotive and manufacturing markets amplified by the impacts of COVID-19. The increase in Wireless Test revenues of $14.5 million, or 50.0%, was primarily due to increased tester demand for 5G cellular and new connectivity standards such as Ultra Wideband.
Revenues by country as a percentage of total revenues were as follows (1):
| For the Three Months Ended |
||||||||
| March 29, |
March 31, |
|||||||
| 2020 |
2019 |
|||||||
| Taiwan |
30 |
% | 17 |
% | ||||
| China |
16 |
17 |
||||||
| Korea |
15 |
10 |
||||||
| United States |
11 |
15 |
||||||
| Europe |
8 |
11 |
||||||
| Japan |
7 |
12 |
||||||
| Thailand |
5 |
4 |
||||||
| Singapore |
3 |
6 |
||||||
| Philippines |
2 |
4 |
||||||
| Malaysia |
2 |
3 |
||||||
| Rest of World |
1 |
1 |
||||||
| 100 |
% | 100 |
% | |||||
| (1) | Revenues attributable to a country are based on location of customer site. |
Gross Profit
Our gross profit was as follows:
| For the Three Months Ended |
||||||||||||
| March 29, |
March 31, |
Dollar/ Point |
||||||||||
| 2020 |
2019 |
Change |
||||||||||
| (in millions) |
||||||||||||
| Gross profit |
$ | 405.6 |
$ | 287.6 |
$ | 117.9 |
||||||
| Percent of total revenues |
57.6 |
% | 58.2 |
% | (0.6 |
) | ||||||
Gross profit as a percent of revenue decreased by 0.6 points, primarily due to product mix in Semiconductor Test.
We assess the carrying value of our inventory on a quarterly basis by estimating future demand and comparing that demand against
on-hand
and on-order
inventory positions. Forecasted revenue information is obtained from sales and marketing groups and incorporates factors such as backlog and future revenue demand. This quarterly process identifies obsolete and excess inventory. Obsolete inventory, which represents items for which there is no demand, is fully reserved. Excess inventory, which represents inventory items that are not expected to be consumed during the next twelve quarters for our Semiconductor Test, System Test and Industrial Automation segments and the next four quarters for our Wireless Test segment, is written-down to estimated net realizable value.During the three months ended March 29, 2020, we recorded an inventory provision of $4.1 million included in cost of revenues primarily due to downward revisions to previously forecasted demand levels, of which $3.0 million was related to Semiconductor Test and $0.5 million was related to Wireless Test.
During the three months ended March 31, 2019, we recorded an inventory provision of $2.4 million included in cost of revenues primarily due to downward revisions to previously forecasted demand levels, of which $1.2 million was related to Semiconductor Test and $0.5 million was related to System Test.
32
During the three months ended March 29, 2020 and March 31, 2019, we scrapped $1.2 million and $0.4 million of inventory, respectively. During the three months ended March 29, 2020 and March 31, 2019, we sold $1.1 million and $0.8 million of previously written-down or
written-off
inventory, respectively. As of March 29, 2020, we had inventory related reserves for inventory, which had been written-down or written-off
totaling $105.3 million. We have no pre-determined
timeline to scrap the remaining inventory.Selling and Administrative
Selling and administrative expenses were as follows:
| For the Three Months Ended |
||||||||||||
| March 29, |
March 31, |
Dollar |
||||||||||
| 2020 |
2019 |
Change |
||||||||||
| (in millions) |
||||||||||||
| Selling and administrative |
$ | 111.4 |
$ | 102.0 |
$ | 9.4 |
||||||
| Percent of total revenues |
15.8 |
% | 20.6 |
% | ||||||||
The increase of $9.4 million in selling and administrative expenses was primarily due to higher sales and marketing spending in Semiconductor Test and Industrial Automation and higher variable compensation.
Engineering and Development
Engineering and development expenses were as follows:
| For the Three Months Ended |
||||||||||||
| March 29, |
March 31, |
Dollar |
||||||||||
| 2020 |
2019 |
Change |
||||||||||
| (in millions) |
||||||||||||
| Engineering and development |
$ | 85.2 |
$ | 76.8 |
$ | 8.4 |
||||||
| Percent of total revenues |
12.1 |
% | 15.5 |
% | ||||||||
The increase of $8.4 million in engineering and development expenses was primarily due to higher spending in Industrial Automation and Semiconductor Test and higher variable compensation.
Restructuring and Other
During the three months ended March 29, 2020, we recorded a gain of $10.0 million for the decrease in the fair value of the AutoGuide and MiR contingent consideration liabilities, partially offset by $1.4 million of acquisition related compensation and expenses and $0.7 million of severance charges related to headcount reductions primarily in Industrial Automation and Semiconductor Test.
During the three months ended March 31, 2019, we recorded an expense of $3.0 million for the increase in the fair value of the MiR contingent consideration liability, $1.3 million of acquisition related compensation and expenses, and $0.8 million of severance charges related to headcount reductions primarily in Semiconductor Test.
Interest and Other
| For the Three Months Ended |
||||||||||||
| March 29, |
March 31, |
Dollar |
||||||||||
| 2020 |
2019 |
Change |
||||||||||
| (in millions) |
||||||||||||
| Interest income |
$ | (2.8 |
) | $ | (5.0 |
) | $ | 2.2 |
||||
| Interest expense |
5.6 |
5.5 |
0.1 |
|||||||||
| Other (income) expense, net |
6.8 |
(1.4 |
) | 8.2 |
||||||||
33
Interest income decreased by $2.2 million primarily due to lower interest rates and lower marketable securities balance in 2020 compared to 2019. Other (income) expense, net increased by $8.2 million primarily due to change in unrealized gains/losses on equity securities, from gains in 2019 to losses in 2020.
Income (Loss) Before Income Taxes
| For the Three Months Ended |
||||||||||||
| March 29, |
March 31, |
Dollar |
||||||||||
| 2020 |
2019 |
Change |
||||||||||
| (in millions) |
||||||||||||
| Semiconductor Test |
$ | 153.8 |
$ | 83.0 |
$ | 70.8 |
||||||
| System Test |
48.4 |
15.3 |
33.1 |
|||||||||
| Wireless Test |
10.2 |
3.6 |
6.6 |
|||||||||
| Industrial Automation |
(15.3 |
) | (5.3 |
) | (10.0 |
) | ||||||
| Corporate and Other (1) |
— |
(2.7 |
) | 2.7 |
||||||||
| $ | 197.1 |
$ | 94.0 |
$ | 103.1 |
|||||||
| (1) | Included in Corporate and Other are the following: contingent consideration adjustments, employee severance, interest (income) and expense, net foreign exchange (gains) and losses, intercompany eliminations, and acquisition related charges. |
The increase in income before income taxes in Semiconductor Test was driven primarily by an increase in semiconductor mobility tester sales resulting from increased complexity of silicon in handsets which drives demand for testers, and an increase in memory test sales of flash and DRAM memory testers. The increase in income before income taxes in System Test was primarily due to higher sales in Storage Test of 3.5” hard disk drive and system level testers, and higher sales in Defense/Aerospace test instrumentation and systems, partially offset by lower sales in Production Board Test due to lower automotive electronics demand. The increase in income before income taxes in Wireless Test was primarily due to increased demand for connectivity, millimeter wave and cellular test products. The decrease in income before income taxes in Industrial Automation was primarily due to lower demand for collaborative robotic arms.
Income Taxes
The effective tax rate for the three months ended March 29, 2020 and March 31, 2019 was 10.6% and (16.1%), respectively. The increase in the effective tax rate from the three months ended March 31, 2019 to the three months ended March 29, 2020 is primarily attributable to the discrete tax benefit from the release of reserves for uncertain tax positions which was recognized in the three months ended March 31, 2019 and a reduction in the benefit from tax credits. These increases were partially offset by a projected shift in the geographic distribution of income, which decreases the income subject to taxation in higher tax rate jurisdictions relative to lower tax rate jurisdictions.
34
Contractual Obligations
The following table reflects our contractual obligations as of March 29, 2020:
| Payments Due by Period |
||||||||||||||||||||||||
| Total |
Less than 1 year |
1-3 years |
3-5 years |
More than 5 years |
Other |
|||||||||||||||||||
| (in thousands) |
||||||||||||||||||||||||
| Convertible debt |
$ | 459,987 |
$ | — |
$ | — |
$ | 459,987 |
$ | — |
$ | — |
||||||||||||
| Purchase obligations |
543,774 |
529,368 |
14,406 |
— |
— |
— |
||||||||||||||||||
| Retirement plans contributions |
130,923 |
5,040 |
10,408 |
10,268 |
105,207 |
— |
||||||||||||||||||
| Transition tax payable (1) |
88,157 |
5,337 |
15,779 |
22,710 |
44,331 |
— |
||||||||||||||||||
| Operating lease obligations |
73,708 |
22,183 |
27,730 |
13,515 |
10,280 |
— |
||||||||||||||||||
| Interest on long-term debt |
23,000 |
5,750 |
11,500 |
5,750 |
— |
— |
||||||||||||||||||
| Fair value of contingent consideration |
20,472 |
662 |
19,810 |
— |
— |
— |
||||||||||||||||||
| Other long-term liabilities reflected on the balance sheet under GAAP (2) |
82,360 |
— |
39,492 |
10,843 |
456 |
31,569 |
||||||||||||||||||
| Total |
$ | 1,422,381 |
$ | 568,340 |
$ | 139,125 |
$ | 523,073 |
$ | 160,274 |
$ | 31,569 |
||||||||||||
| (1) | Represents the transition tax liability associated with our accumulated foreign earnings as a result of enactment of the Tax Reform Act on December 22, 2017. |
| (2) | Included in other long-term liabilities are liabilities for customer advances, extended warranty, uncertain tax positions, deferred tax liabilities and other obligations. For certain long-term obligations, we are unable to provide a reasonably reliable estimate of the timing of future payments relating to these obligations and therefore we included these amounts in the column marked “Other.” |
Liquidity and Capital Resources
Our cash, cash equivalents, and marketable securities balances decreased by $110.7 million in the three months ended March 29, 2020 to $905.0 million.
Operating activities during the three months ended March 29, 2020 provided cash of $43.1 million. Changes in operating assets and liabilities used cash of $172.8 million. This was due to a $150.6 million increase in operating assets and a $22.2 million decrease in operating liabilities.
The increase in operating assets was primarily due to a $126.8 million increase in accounts receivable due to increased sales and a $39.6 million increase in prepayments and other assets, partially offset by a $15.8 million decrease in inventories.
The decrease in operating liabilities was due to a $44.4 million decrease in accrued employee compensation primarily due to first quarter payments related to variable compensation, $1.3 million of retirement plan contributions, a $0.9 million decrease in deferred revenue and customer advance payments, partially offset by a $15.3 million increase in income taxes, a $7.1 million increase in other accrued liabilities, and, a $2.0 million increase in accounts payable.
Investing activities during the three months ended March 29, 2020 used cash of $110.2 million, due to $187.1 million used for purchases of marketable securities, and $36.7 million used for purchases of property, plant and equipment, partially offset by $98.5 million and $15.0 million in proceeds from maturities and sales of marketable securities, respectively, and $0.1 million, net of cash acquired, for the acquisition of AutoGuide.
Financing activities during the three months ended March 29, 2020 used cash of $113.9 million, due to $79.0 million used for the repurchase of 1.3 million shares of common stock at an average price of $58.81 per share, $22.1 million used for payments related to net settlements of employee stock compensation awards, $16.7 million used for dividend payments, and $8.9 million used for a payment related to MiR acquisition contingent consideration, partially offset by $12.8 million from the issuance of common stock under employee stock purchase and stock option plans.
35
Operating activities during the three months ended March 31, 2019 provided cash of $18.0 million. Changes in operating assets and liabilities used cash of $134.2 million. This was due to a $63.3 million increase in operating assets and a $70.9 million decrease in operating liabilities.
The increase in operating assets was primarily due to a $41.7 million increase in accounts receivable due to increased sales, an $18.6 million increase in prepayments and other assets, and a $2.9 million increase in inventories.
The decrease in operating liabilities was due to a $59.5 million decrease in accrued employee compensation primarily due to first quarter payments related to variable compensation, a $22.8 million decrease in income taxes, an $11.5 million decrease in other accrued liabilities, and $1.2 million of retirement plan contributions, partially offset by a $17.7 million increase in accounts payable, and a $6.5 million increase in deferred revenue and customer advance payments.
Investing activities during the three months ended March 31, 2019 used cash of $261.0 million, due to $375.2 million used for purchases of marketable securities, $25.7 million used for purchases of property, plant and equipment, and $7.0 million, net of cash acquired, used for the acquisition of Lemsys, partially offset by $141.2 million and $5.4 million in proceeds from maturities and sales of marketable securities, respectively, and proceeds from life insurance of $0.3 million related to the cash surrender value from the cancellation of a Teradyne owned life insurance policy.
Financing activities during the three months ended March 31, 2019 used cash of $199.8 million, due to $156.5 million used for the repurchase of 4.5 million shares of common stock at an average price of $35.12 per share, $27.6 million used for a payment related to MiR and Universal Robots acquisition contingent consideration, $15.6 million used for dividend payments, and $14.3 million used for payments related to net settlements of employee stock compensation awards, partially offset by $14.3 million from the issuance of common stock under employee stock purchase and stock option plans.
In January 2020, our Board of Directors declared a quarterly cash dividend of $0.10 per share. Dividend payments for the three months ended March 29, 2020 were $16.7 million.
In January 2019, our Board of Directors declared a quarterly cash dividend of $0.09 per share. Dividend payments for the three months ended March 31, 2019 were $15.6 million.
In January 2020, our Board of Directors cancelled the January 2018 stock repurchase program and approved a new stock repurchase program for up to $1.0 billion of common stock. On April 1, 2020, we suspended the share repurchase program. During the three months ended March 29, 2020, we repurchased 1.3 million shares of common stock for $79.0 million at an average price of $58.81 per share. During the three months ended March 31, 2019, we repurchased 4.5 million shares of common stock for $156.5 million at an average price of $35.12 per share.
While we declared a quarterly cash dividend and suspended our share repurchase program, we may reduce or eliminate the cash dividend and may implement a new share repurchase program in the future. Future cash dividends and stock repurchases are subject to the discretion of our Board of Directors, which will consider, among other things, our earnings, capital requirements and financial condition.
On May 1, 2020, we entered into a credit agreement providing for a three-year, senior secured revolving credit facility of $400 million. As of May 4, 2020, we have not borrowed any funds under the credit facility.
We believe our cash, cash equivalents and marketable securities balance will be sufficient to pay our quarterly dividend and meet our working capital and expenditure needs for at least the next twelve months. Inflation has not had a significant long-term impact on earnings. At this time, the
COVID-19
pandemic has not had an impact on our liquidity, but there is no assurance that continued impacts resulting from the pandemic will not have an adverse effect in the future.Equity Compensation Plans
As discussed in Note Q: “Stock Based Compensation” in our 2019 Annual Report on Form
10-K,
we have a 1996 Employee Stock Purchase Plan and a 2006 Equity and Cash Compensation Incentive Plan (the “2006 Equity Plan”).The purpose of the 1996 Employee Stock Purchase Plan is to encourage stock ownership by all eligible employees of Teradyne. The purpose of the 2006 Equity Plan is to provide equity ownership and compensation opportunities in Teradyne to our employees, officers, directors, consultants and/or advisors. Both plans were approved by our shareholders.
Item 3: |
Quantitative and Qualitative Disclosures about Market Risks |
For “Quantitative and Qualitative Disclosures about Market Risk” affecting Teradyne, see Part 2 Item 7A, “Quantitative and Qualitative Disclosures about Market Risks,” in our Annual Report on Form
10-K
filed with the SEC on March 2, 2020. There were no material changes in our exposure to market risk from those set forth in our Annual Report on Form 10-K
for the fiscal year ended December 31, 2019.36
In addition to market risks described in our Annual Report on Form
10-K,
we have an equity price risk related to the fair value of our convertible senior unsecured notes issued in December 2016. In December 2016, Teradyne issued $460 million aggregate principal amount of 1.25% convertible senior unsecured notes (the “Notes”) due December 15, 2023. As of March 29, 2020, the Notes had a fair value of $829.4 million. The table below provides a sensitivity analysis of hypothetical 10% changes of Teradyne’s stock price as of the end of the first quarter of 2020 and the estimated impact on the fair value of the Notes. The selected scenarios are not predictions of future events, but rather are intended to illustrate the effect such event may have on the fair value of the Notes. The fair value of the Notes is subject to equity price risk due to the convertible feature. The fair value of the Notes will generally increase as Teradyne’s common stock price increases and will generally decrease as the common stock price declines in value. The change in stock price affects the fair value of the convertible senior notes, but does not impact Teradyne’s financial position, cash flows or results of operations due to the fixed nature of the debt obligation. Additionally, we carry the Notes at face value less unamortized discount on our balance sheet, and we present the fair value for required disclosure purposes only. In connection with the offering of the Notes we also sold warrants to the option counterparties. These transactions have been accounted for as an adjustment to our shareholders’ equity. The convertible note hedge transactions are expected to reduce the potential equity dilution upon conversion of the Notes. The warrants along with any shares issuable upon conversion of the Notes will have a dilutive effect on our earnings per share to the extent that the average market price of our common stock for a given reporting period exceeds the applicable strike price or conversion price of the warrants or Notes, respectively.| Hypothetical Change in Teradyne Stock Price |
Fair Value |
Estimated change in fair value |
Hypothetical percentage increase (decrease) in fair value |
|||||||||
| 10% Increase |
$ | 901,709 |
$ | 72,271 |
8.7 |
% | ||||||
| No Change |
829,438 |
— |
— |
|||||||||
| 10% Decrease |
759,085 |
(70,353 |
) | (8.5 |
) | |||||||
Item 4: |
Controls and Procedures |
As of the end of the period covered by this report, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule
13a-15(b)
or Rule 15d-15(f)
promulgated under the Exchange Act. The evaluation included any impact to our controls caused by remote working arrangements for a number of our employees due to the COVID-19
pandemic. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective in ensuring that material information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, including ensuring that such material information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.37
PART II. OTHER INFORMATION
Item 1: |
Legal Proceedings |
We are subject to various legal proceedings and claims which have arisen in the ordinary course of business such as, but not limited to, patent, employment, commercial and environmental matters. We believe that we have meritorious defenses against all pending claims and intend to vigorously contest them. While it is not possible to predict or determine the outcomes of any pending claims or to provide possible ranges of losses that may arise, we believe the potential losses associated with all of these actions are unlikely to have a material adverse effect on our business, financial position or results of operations.
Item 1A: |
Risk Factors |
In addition to other information set forth in this Form 10-Q, including the risk discussed below, you should carefully consider the factors discussed in Part I, “Item 1A: Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019, which could materially affect our business, financial condition or future results. The risk factors described in our Annual Report on Form 10-K remain applicable to our business and many of these risks could be further increased due to the COVID-19 pandemic.
The risks described in our Annual Report on Form 10-K are not the only risks that we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.
The novel coronavirus (COVID-19) pandemic has impacted our business and could materially adversely affect our results of operations, financial condition, liquidity or cash flows.
The global outbreak of the recent novel strain of the coronavirus (COVID-19) has resulted in government authorities implementing numerous measures in an effort to contain the spread of the virus, such as travel bans and restrictions, limitations on gatherings or social distancing requirements, quarantines, shelter-in-place orders, and business limitations and shutdowns. These measures have impacted our day-to-day operations and could disrupt our business, workforce and operations, as well as the operations of our customers, contract manufacturers and suppliers for an uncertain period of time. We believe the COVID-19 pandemic, and the numerous measures implemented by authorities in response, has adversely impacted our results of operations, including by increasing costs and decreasing demand in our Industrial Automation businesses, but we cannot accurately estimate the full extent of the impact for our first quarter 2020 financial results or to our future financial results.
The COVID-19 pandemic has significantly increased economic uncertainty in our markets, which could result in a significant decrease in demand for our products for an uncertain period of time. In addition, restrictions on our access to manufacturing facilities or on our support operations or workforce, or similar limitations for our contractor manufacturers and suppliers, and restrictions or disruptions affecting transportation, such as reduced availability of transportation and increased border controls or closures, could limit our capacity to meet customer demand, which could have a material adverse effect on our financial condition and results of operations. The spread of COVID-19 has caused us to modify our business practices, including implementing social distancing protocols, suspending employee travel, requiring most employees to work remotely, canceling physical participation in meetings, events and conferences, and extensively and frequently disinfecting our workspaces, and we may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, customers, contract manufacturers and suppliers. These measures may not be sufficient to mitigate the risks posed by the virus, and our ability to perform critical functions could be harmed. In January 2020, we announced our intention to repurchase $250 million in shares in 2020. However, due to the uncertainty regarding the duration, severity and business impact of the COVID-19 pandemic, as of April 1, 2020, we have suspended our stock repurchase program. At this time, we do not know whether or when we will resume our 2020 repurchase plan or authorize future stock repurchase programs.
We are continuing to monitor the rapidly evolving situation regarding the COVID-19 pandemic and its impact on our business, results of operations, financial condition, liquidity and cash flows. However, despite careful tracking, we are unable to accurately predict the full impact of COVID-19, which will depend on future developments that are highly uncertain and cannot be predicted with accuracy, including, but not limited to, the duration and continued spread of the outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume.
Trade regulations and restrictions could impact our ability to sell products to and support certain customers, which may materially adversely affect our sales and results of operations.
We are subject to U.S. laws and regulations that limit and restrict the export of some of our products and services and may restrict our transactions with certain customers, business partners and other persons. In certain circumstances, export control and economic sanctions regulations may prohibit the export of certain products, services and technologies, and in other circumstances we may be required to obtain an export license before exporting the controlled item. We must also comply with export restrictions and laws imposed by other countries affecting trade and investments. We maintain an export compliance program but there are risks that the compliance controls could be circumvented, exposing us to legal liabilities. Compliance with these laws has not significantly limited our sales, but could significantly limit them in the future. Changes in, and responses to, U.S. trade policy could reduce the competitiveness of our products and cause our sales to drop, which could have a material adverse effect on our business, financial condition or results of operations.
38
The U.S. government from time to time has issued export restrictions that prohibit U.S. companies from exporting U.S. manufactured products, foreign manufactured products with more than 25% controlled U.S. content, as well as U.S. origin technology. For example, the U.S. Department of Commerce has restricted the access of U.S. origin technologies to certain Chinese companies by adding those companies to the Entity List under U.S. Export Administration Regulations (“EAR”).
On May 16, 2019, Huawei and 68 of its affiliates, including HiSilicon, were added to the U.S. Department of Commerce Entity List under the EAR. This action by the U.S. Department of Commerce imposes new export licensing requirements on exports,
re-exports,
and in-country
transfers of all U.S. regulated products, software and technology to the designated Huawei entities. While most of our products are not subject to the EAR and therefore not affected by the Entity List restrictions, certain of our products are currently manufactured in the U.S. and thus subject to the Entity List restrictions. Compliance with the Entity List restrictions has not significantly impacted our sales. In addition, the prohibition on transfers of U.S. origin technology to Huawei could significantly limit our ability to service certain of our products sold to Huawei and our ability to engage in product development activities with Huawei and, therefore, could have a material adverse effect on our business, financial condition or results of operations. Furthermore, Huawei’s inability to obtain products from other companies in its supply chain may adversely impact Huawei’s demand for our products. Huawei or other foreign customers affected by future U.S. government sanctions or threats of sanctions may respond by developing their own solutions to replace our products or by adopting our foreign competitors’ solutions. Also, our controls related to Entity List compliance could be circumvented, exposing us to legal liabilities. Even if such restrictions are lifted, any financial or other penalties or continuing export restrictions imposed on Huawei could have a material adverse effect on our business, financial condition or results of operations.The U.S. Department of Commerce may modify the U.S. EAR to expand the scope of the regulations to include additional products that would become subject to the Entity List restrictions relating to Huawei and the designated Huawei entities including HiSilicon. These modified regulations, if implemented as currently reported, may impact our sales to third party contract manufacturers used by Huawei and HiSilicon to manufacture and test semiconductor and other electronic devices. Because the business environment for Huawei is both fluid and uncertain, there are also risks that Huawei, HiSilicon and their third-party contract manufacturers may have less demand for our products and/or may purchase products from our competitors who are not impacted by the U.S. regulations. Until these or any new regulations become public and effective, we will not know the extent of the impact on our business with Huawei, HiSilicon and their third-party contract manufacturers. However, it is possible that these modified regulations and any other additional regulations that may be implemented by the U.S. Department of Commerce or other government agency would have a material impact on our business and financial results.
On April 27, 2020, the Department of Commerce announced new export controls for certain U.S. products and technology sold to military and civilian end users in China. We do not expect that compliance with the new export controls will significantly impact our ability to sell products to our customers in China or to manufacture products in China. The new export controls, however, could disrupt our supply chain, increase our compliance costs and impact the demand for our products in China and, thus, have a material adverse impact on our business, financial condition or results of operations. In addition, while we maintain an export compliance program, our compliance controls could be circumvented, exposing us to legal liabilities. We will continue to assess the potential impact of the new export controls on our business and operations and take appropriate actions, including filing for licenses with the Department of Commerce, to minimize any disruption. However, we cannot be certain that the actions we take will mitigate all of the risks associated with the new export controls that may impact our business.
Item 2: |
Unregistered Sales of Equity Securities and Use of Proceeds |
In January 2020, our Board of Directors cancelled the January 2018 stock repurchase program and authorized a new stock repurchase program for up to $1.0 billion of common stock. On April 1, 2020, we suspended the repurchase program. During the three months ended March 29, 2020, we repurchased 1.3 million shares of common stock for $79.0 million at an average price of $58.81 per share. During the three months ended March 31, 2019, we repurchased 4.5 million shares of common stock for $156.5 million at an average price of $35.12 per share.
The following table includes information with respect to repurchases we made of our common stock during the three months ended March 29, 2020 (in thousands except per share price):
| Period |
(a) Total Number of Shares (or Units) Purchased |
(b) Average Price Paid per Share (or Unit) |
(c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs |
(d) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that may Yet Be Purchased Under the Plans or Programs |
||||||||||||
| January 1, 2020 – January 26, 2020 |
208 |
$ | 69.05 |
207 |
$ | 985,700 |
||||||||||
| January 27, 2020 – February 23, 2020 |
595 |
$ | 69.90 |
282 |
$ | 965,901 |
||||||||||
| February 24, 2020 – March 29, 2020 |
858 |
$ | 52.59 |
855 |
$ | 920,961 |
||||||||||
| 1,661 |
(1) | $ | 60.85 |
(1) | 1,344 |
|||||||||||
| (1) | Includes approximately three hundred thousand shares at an average price of $69.52 withheld from employees for the payment of taxes. |
39
We satisfy U.S. federal and state minimum withholding tax obligations due upon the vesting and the conversion of restricted stock units into shares of our common stock, by automatically withholding from the shares being issued, a number of shares with an aggregate fair market value on the date of such vesting and conversion that would satisfy the minimum withholding amount due.
Item 4: |
Mine Safety Disclosures |
Not Applicable
40
Item 6: |
Exhibits |
| Exhibit Number |
Description | |||
| 31.1 |
||||
| 31.2 |
||||
| 32.1 |
||||
| 32.2 |
||||
| 101.INS |
XBRL Instance Document | |||
| 101.SCH |
XBRL Taxonomy Extension Schema Document | |||
| 101.CAL |
XBRL Taxonomy Extension Calculation Linkbase Document | |||
| 101.DEF |
XBRL Taxonomy Extension Definition Linkbase Document | |||
| 101.LAB |
XBRL Taxonomy Extension Label Linkbase Document | |||
| 101.PRE |
XBRL Taxonomy Extension Presentation Linkbase Document | |||
| 104 |
Cover Page Interactive Data File (formatted as Inline XBRL, and contained in Exhibit 101) | |||
41
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| TERADYNE, INC. |
| Registrant |
| /s/ Sanjay Mehta |
| Sanjay Mehta Vice President, Chief Financial Officer and Treasurer (Duly Authorized Officer and Principal Financial Officer) |
| May 4, 2020 |
42